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Alzheimer's disease is a progressive neurological ailment affecting 4.5 million 
aging Americans.  The disease is characterized by the presence in the brain of self-
assembled fibrils consisting of beta amyloid protein (Aβ).  Soluble Aβ protein is present 
in normal human cerebrospinal fluid, but it is unclear what makes the protein aggregate 
into insoluble plaques.  There is evidence that the Aβ fibril assembly is affected by 
interactions with biological surfaces, such as neuronal membranes.  Here, surfaces 
consisting of self-assembled alkanethiol monolayers with different end groups were used 
to test the effect of surface chemistry on the structure and morphology of aggregates 
formed from the Aβ peptide.  Reflection-absorption infrared spectroscopy and scanning 
force microscopy (SFM) were used to examine the interactions of the protein with the 
monolayers.  It was found that the surfaces have a seeding effect on the Aβ protein in 
solution and can actually induce aggregation of the Aβ protein over time.  The outcomes 
are important, because the work described here is the first attempt at relating the chemical 
makeup of supported, model monolayer surfaces and their propensity to interact with Aβ 
peptide in solution.  Patterned surfaces consisting of fouling and non-fouling monolayers 
were constructed to determine how these different areas would affect the deposition and 
aggregation of the Aβ protein.  It appeared that the Aβ protein adsorbed onto the ethylene 
glycol even though the ethylene glycol-terminated monolayers alone were previously 
seen to be non-fouling. This was important because it appears that the fouling monolayer 
can induce a change in conformation that allows the protein to stick to what are normally 
non-fouling surfaces.     
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Mica-supported lipid bilayers consisting of 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-
Phosphocholine (POPC) and 1-Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]dodecanoyl]-sn-Glycero-3-Phosphocholine (NBD-PC) were also used as a 
simple cell membrane model system.  Fluorescence photobleaching recovery and SFM 
were used to determine the effects of association of the fibrils with the bilayers.  It was 
found that the Aβ peptide affected the fluidity of the lipid bilayers and inserted itself into 
the lipid bilayer.   This experiment was important because it offers information about the 




Goals, Research Synopsis, and Background 
 
1.1 Research Goals and Aims 
The goal of this research project is to understand the effects of surface chemistry on the 
aggregation of beta amyloid (Aβ) peptide in solution using self-assembled monolayers and lipid 
bilayers as models of biological surfaces. This is an important research area because the Aβ 
peptide is directly linked to Alzheimer’s disease.  Surfaces of self-assembled, ω-substituted 
alkanethiol monolayers supported on Au were used to test the influence of different types of 
chemical moieties on Aβ peptide aggregation.  Aβ peptide in solution was incubated with the 
monolayers to determine the possible impact of the monolayers on the aggregation of Aβ.  
Reflection-absorption infrared spectroscopy was used to provide information on the deposition 
of Aβ peptide onto the monolayers and the conformation of the protein deposits.  Scanning force 
microscopy was used to obtain additional information about the morphology of Aβ aggregates.  
Patterned, self-assembled monolayers consisting of two different types of chemical end groups 
were used to determine the effects of the combination on the Aβ peptide aggregation.  Lipid 
bilayer surfaces were also incubated with Aβ peptide solutions to determine any possible 
interactions between the two entities.  Fluorescence photobleaching recovery and fluorescence 
microscopy were used to evaluate the effect of Aβ protein on the lipid bilayers.  The specific 
aims of this work included: 
• Determine which monolayers adsorb Aβ peptide 
• Verify the conformation of the adsorbed Aβ peptide 
• Determine the extent of Aβ aggregation and aggregate size 
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• Establish whether the monolayers have a seeding affect on the aggregation of Aβ peptide 
in solution 
• Determine whether patterned monolayer surfaces consisting of two different alkanethiols 
promote deposition and aggregation of the Aβ peptide differently than from the single-
constituent monolayers 
• Ascertain the effect that Aβ protein has on the fluidity of the lipid bilayers. 
1.2 Research Synopsis 
The purpose of this research plan is to discover the effects of surface chemistry on the 
aggregation of beta amyloid (Aβ) peptide, the protein that is the hallmark of Alzheimer’s disease.  
It is not precisely known why Aβ peptide aggregates in vivo, but it is speculated that it coincides 
with the environment surrounding the Aβ peptide in the human body as shown in Figure 1.1.  
Surfaces of supported self-assembled monolayers with chemically different end groups were 
used to test this theory.  It was determined that the deposition of Aβ peptide onto the monolayers 
and subsequent aggregation corresponded to the type of end groups on the monolayers and the 
 
Figure 1.1.  Synopsis and motivation of research.   
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properties, such as the hydrophobicity or hydrophilicity, of the end groups.  It was also 
determined whether Aβ peptide has an affinity for certain functional groups on the surfaces and 
what the conformation of the adsorbed Aβ peptide was. The strategy to understanding this 
problem was to fabricate surfaces and let Aβ protein incubate on them.  Initial analysis by 
reflection-absorption infrared spectroscopy was done to reveal possible deposition of Aβ peptide 
to the surface and the conformation of the peptide.  Subsequent analysis by scanning force 
microscopy was done to determine the size and extent of aggregation.  Combinations of different 
types of monolayers patterned on the same surface were also analyzed.  Lipid bilayer surfaces 
were also used as a simplified cell membrane model.  Aβ protein solution was incubated on the 
fluorescent-tagged lipid bilayers to determine the effect that the Aβ protein would have on the 
lipid bilayer fluidity, which was analyzed with fluorescence photobleaching recovery.  This 
study gave information about possible insertion of the Aβ protein into the lipid bilayer, which 
could provide knowledge about the toxicity of the Aβ peptide.  Fluorescence microscopy and 
scanning force microscopy were employed to image the Aβ peptide on the lipid bilayers.   
1.3 Background 
1.3.1 History of Alzheimer’s Disease   
 Alzheimer’s disease is a neurological ailment characterized by plaques and neurofibrillary 
tangles in the brains of humans.  Alois Alzheimer first noted the disease in 1907.1  Scientists 
estimate that around 4.5 million people in the US and 24 million people worldwide have AD.2   
The disease outwardly manifests itself with disorientation, memory loss, mental regression, and 
eventually death of the human.  Autopsies on the brains of humans afflicted with Alzheimer’s 
disease reveal neurodegeneration, atrophy of the frontal, temporal, and parietal cortex, and 
extracellular deposition of fibrillar structures, called amyloid plaques, in the cerebral 
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vasculature.3 These amyloid plaques are thought to be a contributor to the pathogenesis of 
Alzheimer’s disease, and there is a direct correlation between the amount of amyloid plaque and 
the severity of the symptoms of the disease.4  The deposits were originally isolated and 
characterized by amino acid analysis in 1984.5 The major component of these ordered protein 
aggregates is the Aβ peptide. 
1.3.2 Beta Amyloid Precursor Protein 
The genesis of the amyloid deposits have been the focus of a large amount of research 
effort.4  The Aβ peptide originates from a group of 695-770 amino acid residues called the beta 
amyloid precursor protein (APP),6 a normal transmembrane glycoprotein that is generated by the 
endoplasmic reticulum of the cell.7   APP is normally found in brain cell membranes and the 
functions of APP include maintaining connections between brain cell, aiding in the growth and 
repair of brain cells and promoting cell adhesion.8  The soluble Aβ peptide is produced during 
normal cellular metabolism when the APP is cleaved.9  There are two different pathways by 
which the APP is cleaved to form the Aβ peptide.  In the exocytotic processing path, the APP 
undergoes normal proteolytic cleavage by α-secretase as it is released from the cell membrane.10 
In the endocytotic route, the APP is cleaved within the cell membrane by β- and γ- secretase.11 
This proteolytic processing forms the Aβ peptide. 
1.3.3 Beta Amyloid Peptide in the Body 
Aβ peptide is an amphiphilic peptide made up of 39-43 amino acid residues with a 
hydrophilic N-terminus and a hydrophobic C-terminus.12  The Aβ protein has an assortment of 
physiological functions.  In humans, these roles include modulating synaptic function, aiding in 
neuronal growth and survival, shielding against oxidative damage of cerebrospinal fluid and 
plasma lipoproteins, and surveillance against neuroactive compounds and toxins.13  The Aβ 
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peptide is commonly found in the cerebrospinal fluid and plasma of normal humans in the 
soluble form.14-16  Due to unknown causes, the Aβ peptide folds into β-sheet structures in the 
brain of Alzheimer’s disease victims which lead to the formation of insoluble aggregates and 
fibrils17, 18 that are toxic to neuronal cells.19, 20   
1.3.4 Effects of Beta Amyloid Plaques 
Insoluble Aβ protein has a detrimental effect on the human brain.  The Aβ aggregates 
have been shown to alter the mitochondrion of brain cells, which, in turn, causes swelling and 
inflammation of the brain.21  It has been demonstrated that the organized Aβ structures with β-
sheet conformation disrupt cell membranes and cause homeostasis malfunctions and the 
interruption of cellular signals.7, 22, 23  Aβ plaques also destroy synapse by inducing oxidative 
damage to the synapse membrane.24  Neurons are also damaged when the Aβ structures form ion 
channels that allow for the uptake of calcium which causes instability in the normal cellular 
homeostasis.25  All of these processes combine and lead to degradation of the brain, mental 
dementia, and death of the human.     
1.3.5 Surface-Induced Aggregation of Beta Amyloid Peptide 
There is evidence that Aβ fibril assembly is dependent on interactions with biological 
surfaces, such as membranes.26-28  It has been shown that the presence of negatively charged 
lipid vesicles in Aβ solutions shifts the normal random coil conformation of Aβ peptide to a β-
sheet conformation under conditions of low ionic strength.26, 27  This is due to the electrostatic 
binding of Aβ peptide onto the lipid membrane surface and subsequent aggregation of the 
peptide.28  The use of solid state 31P NMR and circular dichroism in solution have demonstrated 
that the composition of lipid bilayers in vesicles (fraction of charged and uncharged lipids) has a 
profound impact on the ability of the vesicle-based lipid bilayers to extract the Aβ peptide from 
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solution and increase is local concentration in the lipid bilayer and initiate random-coil to β-sheet 
conformational changes of monomeric Aβ1-40 in aqueous solution.29  Consequently, it is possible 
that some type of moiety on the cell surface triggers the folding of Aβ peptide and subsequent 
plaque formation.   Therefore, it is important to investigate the influence of surface chemistry on 
the aggregation of the Aβ peptide. 
1.3.6 Self-Assembled Monolayers as Model Surfaces 
A model system was chosen to determine the possible effects of surface chemistry on the 
aggregation of Aβ peptide.  Self-assembled monolayers (SAMs) consisting of chemically 
modified alkanethiol chains on gold substrates were chosen to mimic these biological surfaces.  
These model surfaces were used to determine the effect of surface chemistry on the binding and 
nucleation of the Aβ peptide.   The SAMs imitate small unilamellar lipid vesicles and form a 
stable, ordered surface in which the end groups of the monolayer can be modified. It is proposed 
that the different end groups of the alkanethiol chains will have an effect on the extent and speed 
of aggregation of the Aβ peptide.  Studies of the deposition of the peptide onto the different 
monolayer surfaces have been conducted.  Reflection-absorption infrared spectroscopy (RAIRS) 
and scanning force microscopy (SFM) were used to analyze deposition of the Aβ protein on the 
monolayer surfaces.  The effects of the monolayers on the Aβ protein in solution were also 
analyzed.   
1.3.7 Properties of Self-Assembled Monolayers 
Several ω-substituted alkanethiol monolayers on Au were investigated, such as 
monolayers with methyl (HS-(CH2)17-CH3), alcohol (HS-(CH2)11-OH), carboxylic acid (HS-
(CH2)15-COOH), fluorine (HS-(CH2)2-(CF2)7-CF3), and sulfonic acid (HS-(CH2)10-SO3H) 
functionalities.  Gold was chosen as the supporting substrate because it possesses a clean, 
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ordered surface that allows for the orderly formation of subsequent monolayers.  The surface of 
the gold is arranged in a (111) cubic lattice formation.  The packing order and angle of 
attachment of the monomer units of the monolayer depend on the structure of the monomer 
chain, the interactions between monomer nearest neighbors, and interactions between the 
monomer units and the lattice surface of the gold.30  The angle of attachment of the monolayers 
to the surface is approximately 30˚ with respect to the normal.30  The thickness of the 
monolayers ranges from 10-25 Å depending on the chain length and the angle of attachment.31  
The chains that are more bulky, such as the carboxylic acid chains and the sulfonic acid chains, 
have higher angles of attachment with respect to the normal and are less thick when compared to 
unsubstituted alkanethiols with the same chain length.  The fluorinated monolayer forms a 
hexagonal lattice with approximately 5.8 Å distance between each chain.32 The methyl 
monolayer is also in a hexagonal lattice but has a spacing of 5.0 Å between the chains because 
the unsubstituted alkanethiol chains are less bulky than the fluorinated alkanethiol monolayer.33  
The carboxylic acid monolayer forms a double row configuration on the Au substrate. 34 
1.3.8 Relationship of Self-Assembled Monolayers to Biological Surfaces 
Self-assembled monolayers were chosen because of the wide varieties of surface 
functionalities available that correspond to different biological moieties found in the human 
brain. The carboxylic acid- and alcohol-terminated functionalities produce hydrophilic 
monolayers on Au that are highly polar and have high surface energies.  They are used to model 
the phospholipid bilayers found in cell membranes with hydrogen bonding capabilities. The 
unsubstituted alkanethiol produces a hydrophobic, nonpolar monolayer with a low surface 
energy, which can also be used to model cell membranes. In addition, the hydrophilic sulfonic 
acid-terminated monolayer is similar to heparin from a charged functional group point of view, 
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because the heparin molecule has sulfonic acid functionalities along the protein backbone.35  It 
has been shown that heparin interacts with the Aβ peptide.36-38  Finally, the fluoro-methyl 
monolayer is a very hydrophobic, Teflon-like molecule that is analogous to the apolar side of the 
cell membrane; this is an important parallel because it is thought that when the amyloid 
precursor protein is cleaved within the membrane the toxic species of Aβ is produced. 39, 40 
1.3.9 Patterned Self-assembled Monolayers 
Microcontact printing of alkanethiols was developed by the Whitesides group at Harvard 
in 1993.41  The process is a type of soft lithography that involves using a stamp, usually 
polydimethyl siloxane (PDMS), to transfer an alkanethiol pattern to a metal surface followed by 
backfilling the bare areas by solution deposition of a different ω-terminated alkanethiol solution.  
This method is commonly used to study the interaction of proteins at interfaces and to 
immobilize proteins for various types of detection.   
PDMS is a preferred polymer for stamps because it is a durable material that can be 
reused many times.  It also offers a chemically inert, flexible surface with low surface free 
energy.42  The stamp is “inked” by applying a drop of alkanethiol solution to the stamp, allowing 
the alkanethiol to absorb into the PDMS for a brief amount of time and then drying the stamp 
with nitrogen.  Drying the stamp prevents smearing of the pattern and preserves the arrangement 
of the microcontact printed alkanethiol by reducing the diffusion effects that occur after the 
imprinting is done.  Using a dry stamp circumvents this process by printing the vapor phase 
molecules trapped in the stamp.42  Even though the stamp is dried, ethanol and alkanethiol are 
still present on and in the stamp after drying the stamp because the small amounts of the solution 
are absorbed into the bulk part of the poly siloxane matrix.  The amount of alkanethiol present in 
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the stamp reflects the permeability of the PDMS stamp and the structure of the alkanethiol and 
solvent.43   
The inherent process of autophobic pinning also helps keep the pattern clean by reducing 
diffusion of the alkanethiol.  Autophobic pinning occurs when a liquid in contact with a surface 
alters the chemistry of this surface and lowers its solid-vapor surface tension and solid-liquid 
surface tension, and the liquid edge retracts automatically back to the shape of the stamp.44  The 
formation of a self-assembled monolayer on gold by autophobic pinning is exothermic.45  
Initially the alkanethiols are disordered on the gold surface, and as the alkanethiols find their 
places on the gold lattice the monolayer becomes ordered.  Once the ordered monolayer forms, 
the drop edge of the monolayer spontaneously retracts to the original shape of the stamp.  
1.3.10 Ethylene Glycol-Terminated Alkanethiols 
Poly(ethylene glycol) has been used since the early 1980s.46  Poly(ethylene glycol) is 
well known to be protein resistant.  The steric repulsion model can explain this protein 
resistance.  As the protein moves toward the surface of the poly(ethylene glycol), the 
poly(ethylene glycol) chains collapse which causes steric repulsion with the protein.47  This 
process is applicable for long polyethylene glycol chains.  For shorter chains of oligo(ethylene 
glycol) monolayers, protein resistance is contributed to the water at the protein-oligo(ethylene 
glycol) interface.48  This is known as the water barrier theory.  The water molecules are tightly 
bound to the oligo(ethylene glycol) surface such that the protein cannot adsorb to the 
oligo(ethylene glycol).  Self-assembled monolayers with two repeat units of ethylene glycol do 
adsorb protein due to a more densely packed monolayer, which prevents the water attachment to 
the ethylene glycol units.49  Oligo(ethylene glycol) chains with six monomer repeat units seem to 
be the most protein resistant in all assembly solvents because the oligo(ethylene glycol) 
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monomer has a lower packing density, which allows the water to fully surround the ethylene 
glycol chain, thereby preventing adsorption of hydrophilic proteins. 
Although ethylene glycol end groups are usually known to be non-fouling, a few 
examples in the literature show protein to be attracted to ethylene glycol functionalities.  
Leckband et al. discovered that if streptavidin was forced into contact with a poly(ethylene 
glycol) chain, there existed reasonably strong attractive forces between the protein and the 
poly(ethylene glycol) moiety.50  It has also been shown that mucin, glycoproteins that line the 
gastrointestinal tract, adhere weakly to poly(ethylene glycol).51  Ethylene glycol surfaces that 
have fouling properties can arise by increasing the compression rates or temperature of the 
system, or by varying the polymer molecular weight.52   
1.3.11 Lipid Bilayers as Model Surfaces 
Mica-supported lipid bilayers consisting of 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) and 1-oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino] dodeca-
noyl]-sn-glycero-3-phosphocholine (NBD-PC) (Figure 1.2) were used as a simplified cell 
membrane model system.  Lipid bilayers are physiologically significant because phospholipids 
are principle components of cellular membranes and POPC is one of the main elements of 
mammalian cell membranes.53, 54  These model surfaces were used to determine the effect of the 
Aβ peptide on the fluidity of the lipid bilayers.  Cell membranes in the body are fluid to allow for 
the exchange of vital substance, such as nutrients and waste, into and out of the cell.  This 
experiment is important because it gives information about the insertion and binding of the Aβ 
peptide into cell membranes that could disrupt this cellular homeostasis, which would be 


































Figure 1.2.  Chemical structures of (A) 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) and (B) 1-oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino] dodecanoyl]-sn-
glycero-3-phosphocholine (NBD-PC). 
 
1.3.12 Interaction of Beta Amyloid Protein with Lipid Membranes 
Previous studies have shown that Aβ protein interacts with lipid bilayers and cell 
membranes.   Aβ peptide alters the fluidity of cell membranes such as synaptosomal plasma and 
mitochondrial membranes as shown by polarized fluorescence microscopy.55   It has also been 
shown that the presence of Aβ peptide aggregates causes a decrease in fluidity of POPC bilayers 
as inferred by changes in anisotropy of the bilayer.56  Solution NMR and circular dichroism have 
also been used to track the interaction of Aβ peptide in lipid environments.  These studies 
demonstrated a conformation change from α-helical monomer to β-sheet fibrils that was induced 
by molecular structural characteristics of the membrane.57  Solid-state NMR confirmed that Aβ 
peptide binds to the lipid vesicles and X-ray spectroscopy has shown that Aβ peptide inserts into 
the lipid bilayers.58, 59   
There is evidence that the interaction of Aβ peptide with lipid vesicles is a result of 
electrostatic interactions.  Aβ peptide inserts into normal phospholipid bilayers, but when they 
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are compressed the Aβ peptide is expelled completely from zwitterionic bilayers, such as 1,2-
dipalmitoylphosphatidylcholine (DPPC), while the Aβ peptide remains inserted in the negatively 
charged bilayers, such as 1,2-dipalmitoylphosphatidylglycerol (DPPG).60  It was further 
determined that the DPPG promotes seeding and aggregation of the Aβ peptide on the lipid 
bilayer, while DPPC and dipalmitoyl trimethyl ammonium propane (DPTAP), a positively-
charged lipid, inhibit the aggregation of Aβ peptide.59 
It was first reported that cell membranes in the presence of Aβ peptide showed defects in 
their surfaces.7  This led to further investigations regarding the interactions of cell membranes 
and model lipid bilayers with Aβ peptide.  It was next determined that the gangliosides-bound 
Aβ peptide in the lipid bilayers experienced a conformation change from random coil structure to 
β-sheet structure.61  It was later found that upon binding to cell membranes containing 
gangliosides, the Aβ peptide showed seeding capabilities that promoted further aggregation of 
the Aβ peptide.62  It was initially proposed that the interaction of the Aβ peptide with lipids did 
not rely on charge-charge interactions, but were a result of the hydrophobic areas of the Aβ 
peptide interacting with the hydrophobic core of the lipid bilayers.63  It was also found that the 
presence of cholesterol in the lipid membranes attracts the Aβ peptide and helps immobilize the 
Aβ peptide on the lipid membrane, which promotes the fibrillogenesis of the Aβ peptide.64  The 
use of  31P magic angle spinning NMR demonstrated that in addition to the initial hydrophobic 
interaction of the Aβ peptide with the lipid bilayer there exists an electrostatic component to the 
interaction.65  Solid state 31P NMR was used to further confirm that the adsorption of Aβ peptide 
to lipid membrane is due to electrostatic mechanisms by demonstrating that the Aβ peptide fuses 
with lipid membranes containing different charged headgroups.58  In addition to disrupting the 
membrane fluidity, the Aβ peptide also generates the leakage of the contents of lipid vesicles; 
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which, in turn, could be correlated to the neurotoxicity of the Aβ peptide.56  Further studies 
comparing the type of Aβ peptide that interacts with the lipid bilayers found that the fibrillar Aβ 
peptide greatly reduced the fluidity of the lipid bilayers, while the monomeric, or unaggregated, 
Aβ peptide had a much smaller effect on the fluidity of the lipid bilayers.66  With the discovery 
that the soluble Aβ peptide oligomers were the most likely toxic species of protein, research 
shifted its focus towards analyzing the smaller Aβ peptide aggregates.67  It was determined that 
the oligomeric Aβ peptide changed the molecular structure of the lipid membranes which 
induced a conformational change of the Aβ peptide from the α-helix conformation to the toxic β-
sheet conformation.57 
1.3.13 Techniques Used to Verify Protein Deposition and Aggregation 
Reflection-absorption infrared spectroscopy (RAIRS) was chosen to analyze the 
interaction between the supported ω-substituted alkanethiol monolayers and the monomeric Aβ 
peptide.  Infrared spectroscopy is a good tool for detecting proteins on surfaces because of the 
prominence of the amide I bands at roughly 1600 cm–1 and the amide II bands at roughly 1500 
cm–1.68 The position of these bands also reveals information about the conformation of the 
peptide.  The positions of the amide I and amide II bands for alpha helix conformation, random 
coil conformation, and beta structures of peptides are summarized in Table 1.1. 69, 70 
RAIRS is performed using p-polarized infrared radiation with the electric field oriented 
normal to the surface at a high (grazing) angle of incidence.71  At the high angle, the intensity of 
the infrared is optimized so the sub-micromolar quantities of chemical species can be detected.  
The transmission of the radiation into the Au layer creates a surface standing wave electric field 
that interacts with the vibrational modes of the adsorbates.  The adsorbates must have a 
component of their dipole transition oriented normal to the surface, otherwise the infrared 
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radiation will not be absorbed.71, 72  Curve-fitting deconvolution of the spectra was used to 
resolve overlapped peaks to determine the secondary structure of the protein.  Quantification of 
the amounts of the various secondary structures cannot be performed due to the selection rules 
that apply for RAIRS.71   
Table 1.1.  Position of amide I and amide II IR bands for different protein conformations. 
 
 Amide I peak position (cm-1) Amide II peak position (cm-1) 
Beta sheet 
conformation 









Scanning force microscopy (SFM) is a useful technique that can provide a variety of 
information regarding topography of surfaces.  It was chosen to image alkanethiol monolayers 
and lipid bilayers upon exposure to Aβ protein to obtain information about the size of protein 
species on the different surfaces.  SFM will also be used to understand the physical appearance 
of the aggregates.  When analyzing the patterned monolayers, frictional SFM will be used to 
determine the position of the different chemical functionalities on the monolayers.  
Fluorescence photobleaching recovery (FPR) was also chosen to evaluate the effect of Aβ 
protein on the lipid bilayers.   FPR is a valuable technique that can be used to provide 
information regarding the diffusion coefficient and the fluidity of the lipid bilayers.  
Fluorescence microscopy and in situ SFM was used in conjunction with FPR to image the 
interaction of the Aβ protein with the lipid bilayers.    
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Materials and Methods 
2.1  Chemicals and Products 
Beta amyloid 10-35 [cat # 03-153, lot 0315302, BioSource, 79% peptide content], bovine 
serum albumin [CAS # 9048-46-8, Sigma, 96%], HS-(CH2)17-CH3 [CAS # 2885-00-9, Fluka, 
95%], HS-(CH2)11-OH [CAS # 73768-94-2, Aldrich, 97%], HS-(CH2)11-(OCH2CH2)3-OH [cat # 
TH002-02, lot A2709, ProChimia], 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine in 
chloroform [cat # 850457C, lot 160-181PC-138, Avanti Polar Lipids, Inc.], 1-oleoyl-2-[12-[(7-
nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl] -sn-glycero-3-phosphocholine in chloroform 
[cat # 810133C, lot F181-120NBD-24, Avanti Polar Lipids, Inc.], potassium hydroxide [CAS # 
1310-58-3, Aldrich, 99.99%], phosphoric acid [CAS # 7664-38-2, Aldrich, 99.99%], and 
absolute ethanol [AAPER Alcohol & Chemical Company] were used as received.  HS-(CH2)2-
(CF2)7-CF3 was a gift from Marc Porter at Iowa State University.  The HS-(CH2)15-COOH and 
HS-(CH2)10-SO3H were synthesized previously.1, 2  The poly(dimethyl siloxane) stamp was a gift 
from Yu-Tai Tao at Academia Sinicia in Taipei, Taiwan.  Nanopure water was obtained by 
passing distilled water through a Barnstead reverse osmosis filter and then through a Nanopure 
water system.   
2.2  Methodologies 
2.2.1   Gold Substrate Formation 
Gold substrates for infrared studies were prepared using 1” x 3” glass substrates.  The 
slides were soaked in isopropanol for 30 minutes and then sonicated in isopropanol for 30 
minutes.  The slides were then rinsed with Nanopure water followed by an absolute ethanol 
rinse.  The slides were dried with house nitrogen (liquid nitrogen boil-off) and placed in an 
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Edwards Auto 306 Vacuum Coater.  Deposition of 15 nm chromium was preformed at 3.0 x 10–7 
Torr followed by 200 nm gold at 1.0 x 10–7 Torr.  After removal from the evaporator, the 
substrates were immediately put in ethanol and purged with N2.  The gold substrates for scanning 
force microscopy studies were made using freshly cleaved mica with a deposition of 2000 Å 
gold.  The gold on mica was then annealed at 400 °C for four hours under atmospheric 
conditions.  The gold substrates were subsequently cleaned with UV light and then placed in 
ethanol.    
2.2.2 Monolayer Formation 
Au substrates were rinsed with ethanol and placed in 500 μM solutions of HS-(CH2)17-
CH3, HS-(CH2)11-OH, HS-(CH2)2-(CF2)7-CF3, HS-(CH2)15-COOH, HS-(CH2)10-SO3H, or HS-
(CH2)11-(OCH2CH2)3-OH for a minimum of one hour.  After this self-assembly process, the 
monolayers on Au were rinsed with ethanol and dried under a stream of N2.  The monolayers on 
Au were prepared immediately before they were used in experiments.   
2.2.3 Patterned Monolayer Formation 
 Pattering of monolayers was achieved via microcontact printing.3   A poly(dimethyl 
siloxane), PDMS, stamp with relief lines ranging from 1μm to 10 μm was used.  HS-(CH2)17-CH3 
solution (1 mM in ethanol) was applied to the stamp and allowed to absorb for 30 seconds.  The 
stamp was then dried with N2 and immediately placed on an Au substrate.  Gentle pressure was 
initially applied to ensure complete contact.  After three minutes, the stamp was removed from 
the Au, and the Au/patterned monolayer was rinsed with ethanol to remove unbound thiols from 
the surface.  The sample was then placed in a 1 mM ethylene glycol-terminated solution to allow 
self-assembly of the ethylene glycol-terminated alkanethiol in the bare areas to completely fill in 
the pattern.     
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2.2.4 Lipid Bilayer Formation 
Phospholipid vesicles were prepared via the Morrissey Lab Protocol, yielding a 2 mg/mL 
concentration.4  Briefly, 1.9 mg POPC and 0.1 mg NBD-PC in chloroform was dispensed into a 
13 mm X 100 mm Pyrex test tube.  The lipids were dried under N2 until the chloroform was 
removed by evaporation.  To remove any residual chloroform, the lipids were high vacuumed for 
60 minutes.  A 2-mL aliquot of pH 7.4, 500 mM phosphate buffer was added to the lipids and the 
resulting solution was allowed to sit at room temperature for 60 minutes after which the solution 
was vortexed to resuspend the lipids.  Two methods of forming small, unilamellar vesicles were 
tested.  In the first, the lipid solution was sonicated with a micro-tip Branson Sonifier 450 for 
five minutes to yield a suspension of small unilamellar vesicles.  In the second method, an 
extruder was used to form the small unilamellar vesicles.  The extrusion method was found to be 
superior for forming uniform vesicles.   
Figure 2.1 Schematic of vesicle fusion on a hydrophilic surface. 
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Lipid bilayers were formed via spontaneous lipid fusion.  Briefly, when lipid vesicles 
come in contact with a hydrophilic surface, they spontaneously reorder to form lipid bilayers as 
depicted in Figure 2.1.5  As the vesicle approaches the surface, electrostatic attractions between 
the hydrophilic surface and the vesicle cause the vesicle to spread out onto the surface until the 
vesicle burst and flattens out onto the surface to form a lipid bilayer.  The vesicle solution was 
applied with a pipette onto freshly cleaved mica and allowed to incubate.  After 30 minutes, the 
mica was rinsed with phosphate buffer.  The resulting lipid bilayers were kept moist to prevent 
disassembly of the bilayers.  The formation of the lipid bilayers was confirmed using height 
scanning force microscopy.   
2.2.5 Beta Amyloid Solution Preparation 
Beta amyloid (10-35) solutions were prepared using 15 mM phosphate buffer (no ionic 
strength) and 15 mM PBS/150 mM NaF for experiments at pH 7.4, and 10 mM KOH solution 
for experiments at pH 11.5.  Lyophilized Aβ10-35 peptide was weighed out into a polypropylene 
micro centrifuge tube [cat # RN2000-GMT, Dot Scientific].  The peptide was then dissolved in 
one of the above solutions by vortex to give a final peptide concentration of 100 μM.  Peptide 
concentration was confirmed using amino acid analysis.   
2.2.6 Amino Acid Analysis 
 Peptide concentration of the solutions applied to the supported alkanethiol monolayers 
and the supernatant solutions from the alkanethiol monolayers were determined by amino acid 
analysis of peptide solution hydrolysates.  Amino acid content was determined by 
chromatographic separation with a Dionex 6550 utilizing an anion exchange column and NaOH 
gradient, with an electrochemical detector (Dionex ED50).  The peptide solution was hydrolyzed 
and then injected (4 replicates), and the amino acid content of the individual residues was 
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compared to known amounts of standard, such as norleucine.  The average value from the 4 
replicates was recorded, and it was found that the standard deviation was ±0.01 μM. 
2.2.7 Sample Incubation of Beta Amyloid Protein on Supported Alkanethiol Monolayers 
For experiments involving the deposition of Aβ10-35 peptide on alkanethiol monolayers, 
Aβ10-35 peptide solution was applied onto the monolayers supported on Au to sufficiently cover 
the top of the sample, and then the solution-covered monolayers on Au were placed into a 
container under humidified N2 (Figure 2.2).  The container consisted of a polypropylene jar 
(Nalgene, cat # 2118-0016/500ml); the cover was drilled twice and septa were installed. An 18- 
gauge needle was placed in one of the two septa for exhaust; the other septum had a needle 
connected to a continuous humidified nitrogen purge.  Evaporation of the solution was not 
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Figure 2.2.  Schematic for sample incubation. 
container.  The Aβ solution was allowed to incubate at room temperature on the monolayers for 
15 h.  The Aβ solutions on the HS-(CH2)11-OH, HS-(CH2)2-(CF2)7-CF3, and HS-(CH2)11-
(OCH2CH2)3-OH monolayers were allowed to incubate additionally for 7 days, 20 days, and 40 
days.   Controls consisted of the same solutions made without the Aβ peptide.  After incubation, 
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the monolayers were rinsed with the protein-free KOH solution, dried under a stream of N2, and 
subsequently evaluated with reflection-absorption infrared spectroscopy and scanning force 
microscopy.  Two samples were analyzed for each monolayer to verify reproducibility. 
2.2.8 Preparation of Beta Amyloid Samples for Analysis of Seeding Effects on Alkanethiol 
Monolayers 
 
To analyze the HS-(CH2)11-OH, HS-(CH2)2-(CF2)7-CF3, and HS-(CH2)11-(OCH2CH2)3-
OH monolayers for seeding effects, a separate approach was used.  The 100 μM Aβ peptide 
solutions in ~10 mM KOH at pH 11.5 were prepared as described above.  The high pH inhibits 
the aggregation of the protein in solution, so the possibility of surface-induced aggregation can 
be evaluated.6, 7  In this scenario, the Aβ peptide solution was incubated on the monolayers for 15 
h and 7 days.  After the incubation period, the supernatant from the monolayers was removed 
and spotted onto a mica substrate to allow for adsorption of any solution-phase protein to the 
mica.8  After five minutes, the solution was rinsed away with Nanopure water, and the mica was 
then dried under a stream of N2.  The resulting sample was analyzed by tapping-mode scanning 
force microscopy under ambient conditions.  The control sample, which consisted of the Aβ 
solution in a polypropylene microcentrifuge tube, was prepared and analyzed the same way.   
2.3  Instrumentation and Theory 
2.3.1 Reflection-Absorption Infrared Spectroscopy 
  All reflection-absorption infrared spectroscopy (RAIRS) was performed with a Thermo 
Nicolet Nexus FT-IR model 670 ESP with a MCT (mercury-cadmium-telluride) detector.  The 
instrument was equipped with a Versatile Reflection Attachment with Retro-Mirror Accessory 
(Harrick), in order to perform external reflection measurements.  RAIRS was carried out using p-
polarized light at a grazing incident angle of 86˚ with respect to the surface normal of the sample.  
Samples were placed on a highly reflective gold substrate.  Spectra were obtained using 512 
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scans at a resolution of 4 cm-1.  The purge time, to remove possible contamination from water 
and carbon dioxide vapor, was approximately 9 minutes.  Baseline corrections and subtractions 
for water and carbon dioxide were preformed using Omnic ESP Version 5.2a software.  
Deconvolution of spectra was performed using GRAMS/32 software that utilizes a Fourier  
deconvolution algorithm with a resolution enhancement of 1.4 and a Bessel smoothing factor of 
85%. All spectra were placed on a common scale for comparison.  Bare gold, prepared by UV-
ozone cleaning immediately before use, under the same experimental setup as the samples, was 
used as the reference. The monolayers on Au exposed to both the KOH solution and the Aβ10-35 
in KOH were analyzed separately. 
2.3.2 Theory of Reflection-Absorption Infrared Spectroscopy 
RAIRS, which has become a useful tool for analysis of chemically modified surfaces,9 
was first described in 1966 by Greenler, but it was not widely used until the mid-1980s when the 
method was combined with commercial FTIR spectrometers.10, 11  Infrared spectroscopy works 
by inducing a molecular vibration in a molecule.  Energy is absorbed when the frequency of the 
radiation matches the frequency of the vibration and the absorb energy results in a peak in the 
infrared spectrum.   
The instrumental setup for the spectrometer is as follows:  an IR source produces an 
infrared beam that passes through a Michelson interferometer, which produces an interferogram 
that allows multiple vibrational frequencies to be monitored simultaneously.  The Michelson 
interferometer uses a beamsplitter that divides the infrared beam into two beams.  One beam is 
reflected off a stationary mirror, while the other beam is reflected off a moving mirror.  Both 
beams are combined at the beamsplitter.  Because one mirror is moving the signal that is 
produced when the two beams recombine has a constructive and destructive interference pattern.  
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This is called an interferogram and encodes all frequencies into one beam.  A HeNe laser is 
employed as an internal wavelength calibration standard.  The laser is aligned with the IR source 
and passes through the interferometer with the IR beam and monitors the position of the moving 
mirror.  The wavenumber scale of an interferometer originates from this information.  After 
leaving the interferometer, the IR beam is aimed at a sample on a highly reflective surface.  The 
IR beam is positioned at a grazing angle to the surface normal where the infrared radiation 
interacts with the sample.  The resulting signal is then reflected toward a detector where it is 
measured.  A mathematical Fourier transform is then performed on the signal and an infrared 
spectrum is produced.  The spectrum of the sample is compared with the peaks corresponding to 
the vibrational frequencies of the molecules in the sample to the spectrum of the same system 
with no absorption in the thin layer.   
The intensity of the infrared radiation reflected from a metal substrate depends upon a 
combination of the angle of incidence of the infrared light and the state of polarization of the 
light.  Incident infrared radiation (the light from the source) combines with the infrared radiation 
reflected from the substrate to create a standing wave electric field.  The conditions that produce 
a standing wave with the highest amplitude are the most desirable.  For light polarized 
perpendicular to the plane of incident light (s-polarized) the phase shift remains near to 180° for 
all angles of incidence.10  The addition of the incident vector and reflected vector for the s-
polarized beam cancel each other out almost completely.  Thus, the resulting standing wave 
electric field has a very low intensity and there should be little absorption of infrared light from a 
substrate with reflection of light s-polarized infrared light.  For infrared radiation that is 
polarized parallel to the plane of incident light (p-polarized), the phase shift changes rapidly, 
especially at angles that are high relative to the normal.10  The incident and reflected standing 
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wave vectors at the surface of the substrate are oriented in the same direction and the addition of 
the vectors doubles the intensity of the standing wave.   Therefore, the optimal conditions are 
that the infrared light should be p-polarized and the incident beam should be oriented at a high 
(grazing) angle to the normal of the surface.  At the high angle, the intensity of the infrared is 
optimized so the sub-micromolar quantities of chemical species can be detected.  The resultant 
standing wave electric field vector for p-polarized radiation is predominantly perpendicular to 
the metal surface, which means that those molecular vibrations whose change in electric dipole is 
parallel to the surface will be much less strongly excited.   
Another factor affecting the interaction of the IR beam with the sample is the surface 
selection rule, which concerns how the molecules must be oriented in relation to the metal 
surface.  The metal surface contains free electrons.  When a molecule is adsorbed on a substrate, 
the molecule generates opposite image charges in the electrons in the metal substrate.  If the 
molecule is oriented parallel to the surface, then the dipole moments of the molecule and the 
image charges of the substrate cancel each other out.  When the molecule is adsorbed 
perpendicular to the surface, the dipole moment of the molecule and the resulting image charges 
of the substrate are oriented in the same direction, which gives rise to a dipole moment twice 
what would be expected.  Therefore, only the dipole moments oriented perpendicular to the 
surface will be observed in the vibrational spectrum.9, 12  Quantification of the amounts of the 
various secondary structures on a surface cannot be performed due to the selection rules that 
apply for RAIRS.9   
Infrared spectroscopy is especially helpful for analyzing proteins because of the 
prominence of the amide I bands at roughly 1600 cm–1 due to C=O and C-N stretching and the 
amide II bands at roughly 1500 cm–1 that occur because of N-H bending and C-N stretching.13  
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The position of these spectral bands also reveals information about the conformation of the 
peptide.  The characteristic amide I frequencies are due to distinctive electron densities in the 
amide C=O groups.  These electron densities are produced by the differences in the length and 
direction of hydrogen bonds that give rise to differences in the strength of the hydrogen bond for 
various conformations of the protein.14  When the amide C=O group is engaged in a strong 
hydrogen bond, the electron density in the C=O group will be lower, and an amide I absorption 
band will appear lower.14  The strong intramolecular hydrogen bonding that stabilizes the β-sheet 
conformation is responsible for the low amide I frequencies for that type of conformation.14  The 
β-sheet conformation is also characterized by a split-pattern amide I band composed of a higher 
frequency component.  This high frequency component occurs because of the sterically 
constrained non-hydrogen-bonded amide C=O groups within β-turns.14   The hydrogen bonds 
form between approximately every fourth amino acid in the α-helix conformation, which are 
longer and thus weaker than those formed in a normal β-sheet conformation, so the amide I 
frequencies will be increased.14  A protein with a random coil conformation has the weakest 
hydrogen bonding, so a higher amide I frequency will be present.  The positions of peaks for 
alpha-helix conformation, random-coil conformation, and beta structures of peptides are 
summarized in Table 2.1.15, 16  
Table 2.1.  Position of IR peaks for secondary protein conformations. 
 
Amide I band position (cm-1) Amide II band position (cm-1) 
Beta sheet 
conformation 









2.3.3 Scanning Force Microscopy 
A Digital Instruments Nanoscope III scanning probe microscope controller was used to 
perform all scanning force microscopy (SFM).  A J-type piezoelectric scanner was used that is 
capable of acquiring a scan size of up to 125 μm x 125 μm.  Noncontact silicon cantilevers [cat # 
NSC-15, MicroMasch] were used to obtain the images in tapping mode.  These tips had a radius 
of curvature of 10 nm and a tip height of 15-20 μm, as stated by the manufacturer.  In situ 
scanning force microscopy and lateral force microscopy (LFM) employed silicon nitride 
cantilevers [cat # NP-S, Veeco].  The silicon nitride tips had a radius of curvature of 10 nm and a 
tip height of 2.5-3.5 μm, as stated by the manufacturer.   
Samples were attached to magnetic pucks using adhesive.  Data for ex situ samples were 
taken at room temperature under ambient conditions.  In situ experiments were performed under 
deionized water (18 MΩ cm) or phosphate buffer solution.  Multiple scans from separate areas 
were taken for each sample, and the results shown are representative of the entire sample. 
After capturing the images, an image flatten method was executed.  In the height images 
shown, the brightest areas in the image are the tallest features.  In the force images, the brightest 
areas are the areas that exert the greatest frictional force.   
2.3.4 Theory of Scanning Force Microscopy 
The scanning force microscope apparatus was developed in 1986 by G. Binnig, C. F. 
Quate, and C. Gerber.17-19  The instrument, also known as the atomic force microscope, is 
depicted in Figure 2.3.  Briefly, the SFM operates by measuring attractive and repulsive forces 
between a cantilever tip and a sample.20 The sample is moved under the cantilever tip by a tube 
scanner operated by piezoelectric action.  As the cantilever moves over the surface, a laser 
reflecting off the tip of the cantilever measures the vertical motion of the tip.  The reflected laser 
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is detected by a photodiode which is divided into four quadrants.  The photodiode converts the 
signal into topographical information about the sample.   
Three types of scanning force microscopy were used:  tapping mode SFM, contact mode 
SFM, and lateral force SFM, which is a variation of contact mode SFM.  Tapping mode SFM 
utilizes an oscillating cantilever that taps the sample surface during scanning.  Constant 
oscillation amplitude is maintained.  As the cantilever comes in contact with the surface, the tip 
is deflected, which subsequently shifts the position of the laser beam on the photodiode.  The 
photodiode translates the reflected laser beam into information regarding the vertical height of 
the sample surface.   
Split 





Figure 2.3 Schematic of Scanning Force Microscope. 
 32
Contact mode SFM operates by observing the change in cantilever deflection when 
scanning a cantilever across the sample surface.  A constant deflection force is sustained between 
the cantilever and the sample by vertically moving the scanner, so that the force between the tip 
and sample stays steady.  The photodiode determines the vertical distance that the scanner moves 
by measuring the difference of the laser position between the top two and bottom two quadrants 
of the photodiode.   
Lateral force microscopy (LFM) measures the frictional force of the sample and is used 
in conjunction with contact mode SFM.  As the sample is moved across the cantilever tip, an 
additional twisting motion of the cantilever caused by the differences in friction is measured.  
This twisting motion also changes the position of the laser on the photodiode between the right 
and left quadrants of the photodiode.  As the cantilever scans across high-friction areas, the 
cantilever is torqued more than when scanning across low-friction areas.  The frictional force can 
be described by the following equation: 
F = α (V – V0)        Equation 2.1 
where F is the frictional force, V is the voltage signal due to the deflection in the lateral 
direction, V0 is the voltage signal of the undeflected tip with no frictional force, and α 
conversion factor which is assumed to be constant.   
The interaction of the probe tip and the chemical functionalities in each region of the 
patterned monolayer results in different voltage signals.  The differences in the voltage signal are 
translated into variation in pixel brightness on the image of the surface.   Areas with a higher 
friction produce brighter pixels in the LFM image.  In the experiments involving the deposition 
of Aβ10-35 peptide on patterned alkanethiol monolayers, the probe tip experienced a greater 
frictional force in the areas terminated by the ethylene glycol than in the areas covered in the 
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unsubstituted alkanethiol monolayer.  This occurred because the ethylene glycol-terminated 
monolayer has a higher surface energy than that of the unsubstituted alkanethiol monolayer.21  
2.3.5 Fluorescence Photobleaching Recovery Spectroscopy 
 The Fluorescence Photobleaching Recovery (FPR) apparatus is shown in Figure 2.4.22  
The main element of the FPR instrument is an Olympus BH2 epifluorescence microscope with 
the illuminator assembly adapted to allow illumination by a light source.  A Lexel EXCEL 3000 
argon ion laser capable of producing 2 W at 488 nm is used.  The laser beam is passed through 
an acoustooptic modulator (AOM) [cat # 35085, Newport Research] driven by a modified radio-
frequency source [cat # 31085-6DS, Newport Research].  The first-order diffracted beam, about 
85% of the laser output, is used for photobleaching.  A movable coarse diffraction grating (50, 
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Figure 2.4  Schematic of Fluorescence Photobleaching Recovery Spectroscopy Apparatus. 
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microscope objective is used to produce a striped pattern in the beam.  The patterned beam is 
deflected by a dichroic mirror and focused by the microscope objective (4X, 7X, 10X, and 18X) 
onto the stage, where it can bleach a fluorescently labeled sample.  A photomultiplier tube 
(PMT) [cat # 7265, RCA] receives the fluorescence emitted from the sample.  An 846HP shutter 
[cat # 846HP, Newport Research] remains closed during the photobleaching pulse to protect the 
PMT.  The PMT produces an intensity readout that is sent to a computer where it is translated 
into information regarding the diffusion of the sample.    
2.3.6 Theory of Fluorescence Photobleaching Recovery Spectroscopy 
 Fluorescence photobleaching recovery is a beneficial technique that can be used to 
determine the physical characteristics of large molecules from their diffusion properties.  In 
brief, a laser is used to print a pattern onto a fluorescently labeled sample.  The pattern begins to 
fade and the fluorescence recovery is monitored as the bleached molecules diffuse into the 
unbleached areas of the sample.  The FPR apparatus is arranged such that either a spot or a 
fringed pattern is bleached onto a sample.  In the following experiments, a fringed pattern is 
used.  The fringe pattern is acquired by using a Ronchi ruling located at the rear focal plane of 
the microscope objective lens.  First, the Ronchi ruling is used as a photomask and the sample is 
bleached with a laser.  After bleaching with a laser, a striped image replicating the fringed 
pattern of the Ronchi ruling is imprinted in the sample.  The period of the striped pattern on the 
sample is related to the Ronchi ruling constant, K=2π/L, where L is the period of the repeat 
pattern in the sample.  During the fluorescence recovery phase, the Ronchi ruling is shifted at a 
constant rate through the laser.  This results in a period component in the fluorescence emission 
of the sample as the periodic light field falls into and out of phase with the pattern that was 
bleached into the sample.23  Fluorescence recovery is measured as a function of ac voltage, 
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which corresponds to the contrast of the pattern.  The ac voltage decays exponentially at a rate 
proportional to the diffusion coefficient:  
ac volts = exp (-Γt)       Equation 2.2 
where t is the time since the photobleach, Γ=DK2 where D is the tracer self-diffusion coefficient, 
and K is the grating constant, K=2π/L, where L is the period of the repeat pattern.  The diffusion 
coefficient is obtained from the slope of Γ versus K2 plot.  Size information can also be obtained 
via the Stokes-Einstein equation:  
Ds=kBT/(6πηRB h)        Equation 2.3 
Where kB is the Boltzmann constant, η is the solvent viscosity Rh is the hydrodynamic radius.  
The shape of the molecule is assumed to be spherical.   
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Surface-Induced Aggregation of Beta Amyloid Peptide*
 
3.1 Introduction 
Soluble beta amyloid (Aβ) protein is normally found in the human brain, but due to 
unknown causes, the Aβ peptide folds into β-sheet structures in the brain which, in turn, lead to 
the formation of insoluble aggregates and fibrils.1, 2  These aggregates are toxic to neuronal 
cells.3, 4  There is evidence that Aβ fibril assembly is effected by interactions with biological 
surfaces, such as membranes,5-12 therefore we propose that the physiological environment of the 
Aβ peptide may contribute to the formation of the amyloid plaques that are present in the brains 
of Alzheimer’s patients.   
The goal of the work described here is a better understanding of the effects of surface 
chemistry on the aggregation of Aβ peptide.  Surfaces composed of self-assembled, ω-
substituted alkanethiol monolayers on Au were used to investigate their influence on the 
aggregation of Aβ peptide.  Several different ω-substituted alkanethiol monolayers on Au were 
used, such as those terminated with methyl (HS-(CH2)17-CH3), alcohol (HS-(CH2)11-OH), 
carboxylic acid (HS-(CH2)15-COOH), fluoro-methyl (HS-(CH2)2-(CF2)7-CF3), sulfonic acid (HS-
(CH2)10-SO3H), and ethylene glycol (HS-(CH2)11-(OCH2CH2)3-OH) functionalities.  These 
model surfaces were used to determine the effect of surface chemistry on the deposition and 
aggregation of Aβ peptide.    
Reflection-absorption infrared spectroscopy (RAIRS) and scanning force microscopy 
(SFM) were chosen to evaluate the conformation and topography of Aβ structures on the 
                                            
* Reproduced with permission of Langmuir.  Copyright 2005, American Chemical Society 
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monolayers.  Infrared spectroscopy is a powerful tool for analyzing the conformation of proteins 
because the positions of the amide I and amide II bands are indicative of the environment of the 
amide carboxyl and N-H moieties.13 Scanning force microscopy allows for high-resolution 
imaging of the aggregation behavior of the Aβ protein on the monolayers, specifically the type 
and size of aggregates.   
3.2 Surface-Induced Beta Amyloid Peptide Aggregation – Reflection-Absorption 
Infrared Spectroscopy Studies 
 
To evaluate the ability of the monolayers to induce aggregation only on their surfaces, Aβ 
solutions with a high pH were used.  The high pH inhibits the aggregation of Aβ peptide in 
solution so that the possible effects of the surface on aggregation can be evaluated.14, 15  From 
RAIRS data of various alkanethiol monolayers on Au exposed to N2-purged KOH solutions for 
times up to 40 days (with no protein present), there is no indication of any changes in monolayer 
structure.   
RAIRS is a potent methodology for determining the secondary structural nature of 
proteins in various environments.  The structure of proteins can be correlated with the positions 
of the amide I (C=O stretch, 1600-1700 cm-1) and the amide II (C-N stretch and N-H 
deformation, 1530-1560 cm-1) band frequencies.16-18 The β-sheet conformations are uniquely 
distinguished by a split-pattern amide I band composed of a lower frequency component, 1625-
1640 cm-1, and a less intense, higher frequency component at 1685-1695 cm-1.  In addition, the β-
sheet conformation exhibits an amide II transition between 1530 and 1535 cm-1.  Another 
component of β-structure, namely β-turns, possess bands in the amide I region that are located 
between 1660 and 1680 cm-1; the bands in the amide II region overlap with those of the β-sheet 
structure.  It is common for β-structures to have more that one band present in each region.19 
Random coil conformations are characterized by an amide I band in the 1650-1655 cm-1 region 
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and an amide II band in the 1545-1550 cm-1 region.  α-Helical conformations result in amide I 
transitions centered near 1645-1650 cm-1, as well as an amide II band between 1548 and 1553 
cm-1.  Low frequency amide I bands in the 1600-1625 cm-1 region can be attributed to side chain 
vibrations of the protein.20  



















Figure 3.1.  Reflection-absorption infrared spectra of T-substituted alkanethiol monolayers 
on Au exposed to aqueous solutions of 100 μM Aβ10-35 in 10 mM KOH (pH 11.5) for 15 h. 
 
RAIRS experiments clearly indicate that all of the monolayers on Au investigated here, 
except the HS-(CH2)11-(OCH2CH2)3-OH monolayer, cause deposition of the Aβ peptide, as 
evidenced by observation of amide I and amide II bands for the surfaces studied within a 15-h 
incubation period.  Results are displayed on a common scale in Figure 3.1 for the 15-h 
incubation period.  Curve fitting band deconvolution was performed on each spectrum to resolve 
the overlapped peaks that sometimes occur when two protein conformations are present.21  These 
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results are displayed in Tables 3.1 and 3.2, with the reported values being for the center of each 
band.  Curve fitted spectra are provided in Appendix A.  Spectra of the various thiol monolayers 
on Au exposed to the KOH solutions for a 15-h incubation period (with no protein present) are 
provided in Appendix A.   
Examination of the spectrum for the methyl-terminated monolayer exposed to Aβ 
solutions for 15 h revealed bands in the amide I and amide II regions that are attributed to the 
adsorption, not absorption, of Aβ peptide.  Because no observable change in the peak maxima 
positions for the symmetric (νS, CH) and asymmetric (νA, CH) C-H stretches of the alkane 
moiety of the monolayer were noted, it appears that no absorption of the peptide occurred.  If the 
protein were to penetrate the alkanethiol chains (absorption), disordering of the monolayer 
chains would be expected, leading to changes in the band positions of νS (CH) and νA (CH).22  It 
is concluded that adsorption is the most significant route in the deposition of Aβ on the 
monolayer-modified surfaces.   
Amide I bands resolved by deconvolution of the original spectra were centered at 1632 
cm-1, 1695 cm-1, and 1681 cm-1 (Table 3.1), which indicate a β-sheet conformation; at 1666 cm-1, 
which indicates a β-turn conformation; and at 1649 cm-1, which indicates an α-helix 
conformation.  The presence of both β-structures and α -helix conformations is supported by the 
position of the amide II bands at 1536 cm-1 and 1553 cm-1 (Table 3.2) for the protein deposits.  
Quantification of the amounts of the various secondary structures cannot be performed due to the 
selection rules that apply for RAIRS.23   
Based on similar evaluations of the spectra, it is found that the sulfonic acid-, carboxylic 
acid-, alcohol-, and trifluoromethyl-terminated monolayers all cause adsorption/deposition of Aβ 
peptide on their surfaces.  In addition, all of these surfaces are covered with protein possessing β-
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sheet and β-turn, random coil, and α -helical conformations.  It is important to note that the 
ethylene glycol-terminated monolayers24, 25 do not exhibit IR spectra characteristic of Aβ peptide 
adsorption, for times up to 40 days, which was the limit of our study. 
 
Table 3.1.  Amide I band positions for the deconvoluted RAIR spectra of monolayers 
exposed to 100 μM Aβ10-35 in 10 mM KOH (pH 11.5) for 15 h. 
 
Band positions for deconvoluted amide I transitions  
in Figure 3.1 (cm-1) 
 
 
Monolayer system β-sheet β-turn Random 
coil 
α-helix Side chain 
HS-(CH2)17-CH3 1632, 1695, 
1681 
1666 - 1649 1616, 
1603 
HS-(CH2)11-OH 1636, 1687 1665 - - 1615, 
1601 




- - 1618, 
1607 
HS-(CH2)15-COOH 1632, 1693 1673  1648 - 
HS-(CH2)10-SO3H 1638, 1689, 
1681 
1678, 1669 1655 - 1617, 
1603 
 
Table 3.2.  Amide II band positions for the deconvoluted RAIR spectra of monolayers 
exposed to 100 μM Aβ10-35  in 10 mM KOH (pH 11.5) for 15 h. 
 
Band position for deconvoluted amide II transitions in 
Figure 3.1 (cm-1) 
 
 
Monolayer system β-structures Random coil α-helix 
HS-(CH2)17-CH3 1536 - 1553 
HS-(CH2)11-OH 1539 - - 
HS-(CH2)2-(CF2)7-CF3 1539 - - 
HS-(CH2)15-COOH 1537 - 1549 
HS-(CH2)10-SO3H 1534 - - 
 
 
Further analysis of the fluorinated monolayer with longer incubation times revealed that 
the protein conformations present changed slightly over a period of 20 days (Figure 3.2), with a 
minor shift from β-structure towards α-helical conformations.  Curve fitting band deconvolution 
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was performed on each spectrum in Figure 3.2 to resolve overlapped peaks.  These results are 
displayed in Table 3.3, with the values shown being for the center of each band.  Curve fitted 
spectra are provided in Appendix 1. 
















Figure 3.2.  Reflection-absorption infrared spectra of CF3-(CF2)7-(CH2)2-SH/Au exposed to 
aqueous solutions of 100 μM Aβ10-35  in 10 mM KOH (pH 11.5) for 15 h, 7 days, and 20 
days.   
 
 
Table 3.3.  Band positions for the deconvoluted RAIRS spectra of CF3-(CF2)7-(CH2)2-
SH/Au exposed to 100 μM Aβ10-35 in 10 mM KOH (pH 11.5) for 15 h, 7 days, 20 days.   
 
Band positions for deconvoluted amide I 
transitions in Figure 3.2 
Band positions for deconvoluted 


















- - 1539 - - 
7 days 1637, 
1689, 1681 
1670 1654 - 1538 - 1547 
20 days 1633, 1680 1662 - 1644 1534 1550 - 
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The position of the amide I bands remained stable for the fluorinated monolayer, 
indicating the presence of β-structures for incubation times of 15 h, 7 days, and 20 days.  
Additionally, the Aβ peptide incubated on the fluorinated monolayer for 7 days had a random 
coil conformation indicated by the band centered at 1654 cm-1.  The Aβ peptide incubated on the 
fluorinated monolayer for 20 days had an α-helix conformation in addition to the β-structure 
conformation.  Intramolecular hydrogen bonding can explain the presence of the α-helix 
conformation.  Intramolecular hydrogen bonding is promoted after a protein is adsorbed onto a 
hydrophobic surface because it is unlikely that the protein will form hydrogen bonds with the 
monolayer since the monolayer is terminated with fluorocarbon endgroups.26  When compared 
on a common scale, the intensities of the amide I and amide II bands increased over time, an 
observation that indicates that the monolayer had more Aβ peptide deposited on it as time 
progressed.  Since the dipole moment of the C=O group (amide I band) is oriented orthogonally 
to that of the C-N group (amide II band) on the protein and both band intensities increase, it can 
be concluded that this increase is due to a growth in the amount of peptide on the surface and not 
just a change in orientation. 
3.3 Surface-Induced Beta Amyloid Peptide Aggregation – Scanning Force Microscopy 
Studies 
 
The fluorinated monolayer was chosen for in-depth SFM studies due to the observation in 
the RAIRS studies that the CF3-layer accumulated more Aβ than the other surfaces as a function 
of time.  SFM inspection of the fluorinated monolayer was made at 15 h, 7 days, and 20 days of 
exposure to the Aβ solution; the results are displayed in Figure 3.3.  In Figure 3.3A is shown the 
SFM image of the CF3 monolayer on Au exposed to KOH for 15 h demonstrating the absence of 








Figure 3.3.  2 μm x 2 μm tapping mode scanning force micrographs of CF3-(CF2)7-(CH2)2-
SH/Au exposed to: A. 10 mM KOH for 20 days; B. 100 μM Aβ10-35  (in 10 mM KOH, pH 




After 15 h of exposure to the Aβ solution, rod-like aggregates approximately 150 nm in 
length and 25 nm in height had formed (Figure 3.3B) on the fluorinated monolayer.  By 7 days of 
exposure, the aggregates of Aβ peptide were observed to be roughly 300 nm in length and 50 nm  
in height (Figure 3.3C).  Aggregation length and height for the largest particles had reached 450 
nm and 50 nm by day 20 (Figure 3.3D).  The length of individual aggregates was judged to be 
their greatest lateral dimension.  SFM can be used to give only partial information about the 
length of the aggregates because tip-sample convolution can limit resolution.27  
The SFM results are in agreement with the findings of the time-dependent RAIRS work.  
Both studies indicate that the Aβ peptide continues to deposit on the monolayer with time, and 
the RAIRS data allow it to be concluded that the types of peptide conformations present do not 
change significantly with increased exposure time.  SFM confirms that more Aβ peptide is 
adsorbed to the surface of the monolayer as exposure time is increased.    
3.4   Seeding Effects of the Monolayers 
An additional question to be addressed is whether Aβ aggregates that are adsorbed to the 
monolayer surfaces dissociate from the monolayer and enter solution.  If the aggregates do 
dissociate from the monolayers, it is expected that they would act as seeds for initiating 
aggregation of Aβ protein in the solution.28  A comparison between the supernatant from the 
fluorinated, alcohol, and ethylene glycol monolayers and a control, which consisted of the Aβ 
solution in a polypropylene microcentrifuge tube, was conducted using scanning force 
microscopy.  A high-pH solution was used to retard aggregates from forming. Multiple SFM 
scans from various areas on the samples were performed, and the results shown are 
representative of the entire sample surfaces.   
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The results from the control, which consisted of Aβ peptide solution from a 
polypropylene vial that was subsequently spotted onto mica for analysis, are displayed in Figure 
3.4A-B.  After a 15-h incubation period, the solution had formed very few aggregates, Figure 
3.4A.  The aggregates that had formed were approximately 40 nm in length and 25 nm in height.  
Following an incubation of 7 days, the aggregates were larger, with lengths ranging from 75 to 




Figure 3.4.  10 μm x 10 μm tapping mode scanning force micrographs of 100 μM Aβ10-35 
peptide in 10 mM KOH solution at pH 11.5 from a vial incubated at room temperature for 
A. 15 h and B. 7 days.  For experiments, 50 μL of solution was spotted on mica, allowed to 
sit for 5 minutes, and then the resulting surface was rinsed with 18 MΩ-cm water and 
dried. Z-range=50 nm. 
 
After a 15-h incubation of the Aβ solution with the CF3 monolayer, the Aβ protein had 
formed many aggregates in solution approximately 40 nm in length and 25 nm in height.  
Following a 7-day incubation with the CF3-layer, the Aβ aggregates were larger, with lengths 
ranging from 75 to 100 nm and heights of approximately 40 nm, Figure 3.5A.   
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In order to probe the effects of the monolayer on the production of the Aβ aggregates in 
solution, a study involving the alcohol monolayer was pursued.  After a 15-h incubation of the 
Au-supported, alcohol-terminated alkanethiol with the Aβ solution, protein aggregates 
approximately 60 nm in length and 25 nm in height were observed (data not shown).  After 7 
days of incubation, the Aβ protein had formed larger aggregates approximately 50 nm in height 




Figure 3.5.  10 μm x 10 μm tapping mode scanning force micrographs of 100 μM Aβ10-35 
peptide in 10 mM KOH solution at pH 11.5 from various experiments.  A. Supernatant 
from the CF3-(CF2)7-(CH2)2-SH/Au monolayer exposed to 100 μM Aβ10-35  peptide in 10 
mM KOH for 7 days.  B. Supernatant from the HO-(CH2)11-SH/Au monolayer exposed to 
100 μM Aβ10-35  peptide in 10 mM KOH for 7 days.  For experiments, 50 μL of supernatant 
was spotted on mica, allowed to sit for 5 minutes, and then the resulting surface was rinsed 
with 18 MΩ-cm water and dried. Z-range=50 nm. 
 
After analysis of the Aβ solutions, it is clear that the Aβ solution from the polypropylene 
vial, which was the control, exhibited very little protein aggregation.  The Aβ solution from the 
fluorinated monolayer experiment had a much greater extent of peptide aggregation than the 
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control, while the alcohol monolayer had the most aggregation of Aβ protein, as judged by 
aggregation length and number.  In comparison, the Aβ protein solution taken from the ethylene 
glycol-terminated monolayer exhibited very little protein aggregation (Figure 3.6A), which was 
comparable to the control from the vial.  The ethylene glycol-terminated monolayer did not 




Figure 3.6.  10 μm x 10 μm tapping mode scanning force micrographs of 100 μM Aβ10-35 
peptide in 10 mM KOH solution at pH 11.5.  A. Supernatant from the HS-(CH2)11-
(OCH2CH2)3-OH /Au monolayer exposed to 100 μM Aβ10-35  peptide in 10 mM KOH for 40 
days.  B. HS-(CH2)11-(OCH2CH2)3-OH / Au monolayer exposed to 100 μM Aβ10-35  peptide 
in 10 mM KOH for 40 days.  For the supernatant experiments, 50 μL of supernatant was 
spotted on mica, allowed to sit for 5 minutes, and then the resulting surface was rinsed with 
18 MΩ-cm water and dried. Z-range=50 nm. 
 
aggregation in solution.  If the protein does not adsorb to the monolayer surface, there is not a 
nucleus present for seeding polymerization to begin.  These results indicate that the Aβ 
aggregates do dissociate from the monolayers after their formation.  However, in consideration 
of the SFM images of the exposed monolayer surfaces themselves (not shown) and of the RAIRS 
data (vide supra), it was evident that the fluorinated monolayer possessed more protein deposits 
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than did the alcohol monolayer.  Therefore, for the fluorinated monolayer, there would be less 
protein available in solution from which aggregates would form.   
Amyloid solutions before and after incubation with the alcohol- and fluoromethyl-
terminated monolayers were evaluated to determine the peptide content (amino acid analysis) of 
the solution after incubation.  Results confirmed the initial hypothesis regarding the difference 
between the adsorption propensities of the different monolayers, that is, the CF3 monolayer had 
removed more Aβ peptide from the solution than had the alcohol-terminated monolayer.  Amino 
acid analysis of the solutions after incubation revealed that the peptide content of the solution 
from the fluorinated monolayer was less than that of the alcohol monolayer by a factor of 10.  
Therefore, the reason the alcohol monolayer had more of a seeding effect was because there was 
more peptide in the solution for aggregates to form from the displaced seeds.  In addition, by 
comparing the solutions from the monolayers with the solution from the polypropylene vial and 
the ethylene glycol-terminated monolayers on Au (controls), it can be concluded that the 
monolayers do induce aggregation of the Aβ peptide in solution, because the controls does not 
have the extent of aggregation that the solution from the monolayers have.   
In Figure 3.7 is depicted a proposed model describing the interaction of the Aβ peptide 
with the monolayer surfaces.  Initially, the Aβ peptide is adsorbed onto the monolayer surface (A 
to B), where it subsequently undergoes a change in conformation to a β-sheet (B to C).  At this 
stage, the process can then follow two pathways. In one path (C to D), the surface accrues more 
peptide due in part to the confined β-sheet form acting as a template to yield larger surface-
confined aggregates.  In the second path (C to E), the β-sheet form of the peptide on the 
monolayer is moved to solution wherein the folded peptide (monomer or higher-order 
aggregates) interacts with monomeric Aβ peptide to form larger aggregates (E to F).  These 
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larger, solution-phase aggregates can either continue to grow upon interaction with monomeric 













Dislodged Folded Protein 








Figure 3.7.  Model of the surface interaction and subsequent aggregation of Aβ10-35 peptide 
exposed to various ω-substituted alkanethiol monolayers.   
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The surface-induced aggregation of Aβ peptide as a route to the formation of solution-
phase aggregates and surface-bound aggregates is an important issue in understanding the 
mechanism of action of Aβ peptide aggregates and their role in Alzheimer’s disease.6, 12 
Although the impact of surface charge of lipid bilayer vesicles on the interaction of Aβ peptide 
with such lipid membranes has been demonstrated,6-9 little information exists surrounding the 
relationship between the deposition, folding and aggregation of solution-phase Aβ peptides and 
the chemical nature of non-ionic surfaces. The work described here is a first attempt at relating 
the chemical makeup of supported, model monolayer surfaces and their propensity to interact 
with Aβ peptide in solution. The outcomes are important, for it is clear that the relatively “non-
specific” interactions of Aβ peptides with certain surfaces may be similar to that observed for 
ganglioside-terminated lipid vesicles, the latter which have been shown to cause formation of Aβ 
peptide β-sheets.29   
3.5   Conclusions 
Reflection-absorption infrared spectroscopy analysis revealed that deposition of Aβ10-35 
occurred onto both hydrophilic and hydrophobic surfaces under conditions that do not lead to 
aggregation in solution.  In addition, the RAIRS studies demonstrated that the conformation of 
the adsorbed Aβ10-35 does not change over a period of 40 days of exposure, and the amount of Aβ 
deposited increases with exposure time.  Scanning force microscopy confirmed that the amount 
of aggregated deposits increased with exposure time.  Studies of the solutions exposed to 
monolayers revealed that the monolayers have a seeding effect on Aβ peptide in solution, leading 
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Effect of Patterned Monolayers with Different Chemical Functionalities on the Surface-
Induced Aggregation of the Beta Amyloid Peptide 
 
4.1 Introduction 
It has been found that Au surfaces consisting of self-assembled monolayers (SAMs) 
terminated with methyl (HS-(CH2)17-CH3), alcohol (HS-(CH2)11-OH), carboxylic acid (HS-
(CH2)15-COOH), fluoro-methyl (HS-(CH2)2-(CF2)7-CF3), sulfonic acid (HS-(CH2)10-SO3H) 
chemical functionalities, adsorbed Aβ protein (fouling) and could induce the aggregation of Aβ 
protein in solution, and that SAM surfaces terminated with ethylene glycol (HS-(CH2)11-
(OCH2CH2)3-OH) chemical functionalities did not adsorb Aβ protein (non-fouling) or cause 
aggregation of the Aβ protein in solution.  The next step in this series of experiments was to form 
patterned surfaces consisting of monolayers with fouling and non-fouling surface properties to 
determine if areas of fouling monolayers embedded in non-fouling monolayers affected the 
deposition of the Aβ protein on both of these surfaces or the aggregation of the Aβ protein in 
solution.  This system was used to model a cell membrane that has a particular type of isolated 
chemical functionality which could act as a nucleation site for inducing aggregation of Aβ 
protein on a surface that would not usually affect the Aβ protein.  This is an important model 
because it has been shown that Aβ protein will bind to gangliosides implanted in lipid vesicles, 
and this immobilized protein can act as a nucleation seed to form the Aβ protein aggregates.1-3  
The formation of aggregated Aβ protein from soluble Aβ protein by seeded polymerization is 
regarded as a crucial step in the progress of Alzheimer’s disease.4   
Microcontact printing was chosen to construct the patterned monolayer surfaces.  This 
technique is generally used to control topographical features and spatial presentation of surface 
molecules.  Microcontact printing has become a useful tool in the manufacture of microanalytical 
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devices, such as chemical and biological sensing devices.  Patterned monolayers are also 
commonly used as model system for studying protein deposition at interfaces.5-8    
Ethylene glycol functionalities are commonly used as a surface coating to prevent non-
specific protein deposition.  Several literature studies have revealed that an ethylene glycol-
terminated SAM, HS(CH2)11(OCH2CH2)3OH on Au, is resistant to protein deposition.9-11  
Preliminary reflection-absorption infrared spectroscopy (RAIRS) and scanning force microscopy 
(SFM) studies showed that the ethylene glycol-terminated SAM was non-fouling for the Aβ 
protein for up to a forty-day incubation period (Figures 3.1 and 3.6).  Therefore, it appeared that 
this SAM was suitable to be used as a non-fouling model surface in the Aβ protein on patterned 
monolayer experiments.  The methyl-terminated alkanethiol monolayer, HS(CH2)17CH3 on Au, 
was shown to adsorb the Aβ protein in the previous studies (Figure 3.1), so it was a suitable 
coating to be used for the fouling areas in the patterned monolayer surfaces.  The methyl-
terminated alkanethiol was chosen over the other fouling alkanethiol monolayers because it 
resists degradation and has a chemical composition similar to cell membranes.5, 12-15   
4.2 Motivation  
The aim of this project was to use a patterned monolayer surface constructed via 
microcontact printing of a fouling SAM, HS(CH2)17CH3 on Au, surrounded by a non-fouling 
SAM, HS(CH2)11(OCH2CH2)3OH on Au, to determine the effect that the small, fouling areas 
have on the deposition and aggregation of the protein in the presence of a non-fouling 
monolayer. This experiment was used to gain a better understanding of how surfaces, 
specifically the combination of fouling and non-fouling areas on the same surface, influence the 
aggregation of Aβ peptide.  SFM and lateral force microscopy (LFM) were used to detect and 
monitor the protein on the patterned surfaces.  Because of the tribological variances of the two 
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types of monolayers, LFM was used to distinguish between different types of chemical 
functionalities present in the pattern.  Height-mode SFM was used to determine where the Aβ 
protein had adsorbed to the monolayer surface.   
There are several questions to be answered by this experiment.  It will be informative to 
observe how the combination of fouling and non-fouling areas affects the adsorptive properties 
of each other.  It could be determined whether the protein will still adhere to the fouling 
monolayer in the presence of a non-fouling monolayer, and if the non-fouling monolayer resists 
all protein deposition in the presence of a fouling surface.  If the protein does adsorb onto the 
fouling monolayer, it could further be determined if the protein remains confined to that fouling 
monolayer.  It is possible that the seeding effect of the fouling monolayer has the capacity to 
cause the protein to grow onto the non-fouling surface, which could possibly give insight to how 
Aβ plaques form in the brain.  Previous studies indicate that the protein can absorb on a fouling 
monolayer, form larger aggregates and then desorb from the surface into solution where it acts as 
a nucleus for further aggregation in solution, which is called the seeding effect of the surface.   
In the previous studies analyzing the seeding effect of the monolayers, the alkanethiol 
monolayer induced aggregation of the protein in solution, while the ethylene glycol-terminated 
monolayer seemed to prevent aggregation of the protein in solution.  Therefore, the effect of the 
combination of the surface fouling and non-fouling moieties on the aggregation of the protein in 
solution will also be determined.  If the protein does desorb from the surface, it will also be 
verified what happens to the protein after desorption.  It is also possible that the aggregated 
protein could desorb from the fouling surface and drop back down on the non-fouling surface.  It 
will be determined if the protein would settle on the non-fouling surface and continue to 
aggregate on that surface.   
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4.3 Experimental 
The patterning of the monolayer was constructed via microcontact printing.16  
Poly(dimethyl siloxane), PDMS, stamps with different size patterns were used.  Two different 
sizes of patterns were used to determine if the dimensions of the fouling and non-fouling areas 
affected the deposition of the aggregates of Aβ protein to the surfaces.  Methyl-terminated 
alkanethiol, HS(CH2)17CH3, in ethanol was applied to the stamp and allowed to absorb for 30 
seconds.  The stamp was then dried with N2 and immediately applied to a freshly cleaned Au 
substrate.  After three minutes, the stamp was removed from the Au, and the Au/patterned 
methyl-terminated alkanethiol monolayer was placed in an ethylene glycol-terminated 
alkanethiol solution, HS(CH2)11(OCH2CH2)3OH, in ethanol.  The ethylene glycol-terminated 
alkanethiol then self-assembled in the bare areas to completely fill in the pattern.  A patterned 
monolayer is shown in Figure 4.1.  The height image (left side) was relatively smooth displaying 
the Au (111) crystallite features associated with the monolayer-covered Au surface while the 
friction image (right side) exhibited the differences in the surface energy of the separate chemical 
functionalities.  The light color in the Z-range friction scale of the LFM images represents a 
higher surface friction.  Therefore, in this and all of the following figures, the ethylene glycol-
terminated monolayer correlate to the lighter areas of the LFM images, while the methyl-
terminated alkanethiol monolayer were the darker areas of the LFM images.   
After the patterned monolayers were formed, they were incubated with Aβ protein for 
various amounts of time.  Analysis was done using in situ SFM while incubating the Aβ protein 
with the patterned monolayer so that the formation of the Aβ aggregates could be analyzed in 
real time.  Analysis was done using SFM and LFM to simultaneously measure the height and 





Figure 4.1.  5.4 μm x 5.4 μm contact mode scanning force micrographs of a patterned 
monolayer on Au.  The height image is on the left and the friction image is on the right.  In 
the friction image the HS(CH2)11(OCH2CH2)3OH monolayer is evidenced by the lighter 
areas.  The Z-range is 10 nm for the height image and is 0.5 V for the friction image.   
 
4.4 Deposition of Beta Amyloid on a Small-Scale Patterned Monolayer 
 In situ SFM was performed to monitor possible deposition and aggregation of Aβ protein 
on the patterned monolayer.  A small scale patterned was originally chosen.  The stamp consisted 
of small areas with repeat pattern widths of 1 μm.  Approximately 15% of the resulting patterned 
monolayer consisted of the fouling HS(CH2)17CH3 monolayer.  Initial analysis was done with a 
patterned monolayer that had been exposed to 100 μM beta amyloid in 10 mM KOH solution at 
pH 11 for 15 hours (Figure 4.2).  The spacing of the line pattern was approximately one 
micrometer apart.  The height SFM image is located on the left, while the right side contains the 
frictional LFM image.  The brighter color in the Z-range scale of the LFM images represents a 
higher surface friction.  Therefore, in Figures 4.2 and 4.3, the ethylene glycol-terminated 
monolayer are depicted by the lighter areas of the LFM image, while the alkanethiol monolayer 
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are the darker areas of the LFM image.  This difference in friction occurred because the ethylene 
glycol functionality had a higher surface energy than the unsubstituted alkanethiol 
functionality.17  When the Aβ protein was incubated on a small-scale pattern of the fouling and 
non-fouling monolayers, it appeared that the Aβ protein adsorbed onto the ethylene glycol 
domains even though the ethylene glycol-terminated monolayers were supposed to be non-
fouling. After the Aβ protein had been incubated on the patterned monolayer for 40 hours, the 
Aβ protein spread significantly onto the ethylene glycol-terminated portion of the monolayer 
(Figure 4.3).  The aggregates were approximately 100 nm in length and 25 nm in height.  This 





Figure 4.2.  5 μm x 5 μm in situ contact mode scanning force micrographs of a patterned 
monolayer exposed to 100 μM beta amyloid in 10 mM KOH solution at pH 11 for 15 hours.  
The height image is on the left and the friction image is on the right.  In the friction image 
the HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas.  The Z-range is 50 







Figure 4.3.  5 μm x 5 μm in situ contact mode scanning force micrographs of a patterned 
monolayer exposed to 100 μM beta amyloid in 10 mM KOH solution at pH 11 for 40 hours.  
The height image is on the left and the friction image is on the right.  In the friction image 
the HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas.  The Z-range is 50 
nm for the height image and 0.1 V for the friction image. 
 
monolayer exhibited negligible Aβ protein deposition.  In this case, boundary failure of the 
patterned monolayer was found, which is defined as the invasion of the protein onto the non-
fouling regions.  The adsorptive properties of the methyl-terminated monolayer appear to be 
stronger than the protein-resistant characteristics of the ethylene glycol-terminated monolayer 
because the Aβ protein was present on the ethylene glycol-terminated portion of the monolayer.  
In this situation, it appears that the Aβ protein did not grow onto the non-fouling monolayer from 
the fouling monolayers, but rather nucleated and aggregated on the fouling monolayer, then 
desorbed from the fouling monolayer and readsorbed on the non-fouling monolayer surface.  The 
spacing of the two monolayers could be too close together allowing for mixing of the 
monolayers to occur since the monolayers are slightly fluid.17, 18  If the monolayers are mixed, 
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the Aβ protein would adsorb onto the few HS(CH2)17CH3 chains present in the 
HS(CH2)11(OCH2CH2)3OH areas.   
4.5  Deposition of Beta Amyloid on a Large-Scale Patterned Monolayer 
 A larger-scale pattern was chosen next to determine if the closeness of the two 
monolayers could be the reason the Aβ protein was able to adsorb onto the ethylene glycol 
monolayers.  The PDMS stamp used in these studies was constructed using a semiconductor 
wafer as a negative relief pattern.  This stamp provided a variety of patterns on the same stamp 
with repeat pattern widths ranging from 10 μm to 20 μm.   Approximately 12% of the resulting 




Figure 4.4.  50 μm x 50 μm scanning force micrographs of a patterned monolayer exposed 
to 100 μM beta amyloid in 10 mM KOH solution at pH 11 for 12 hours. The height image is 
on the left and the friction image is on the right.  In the friction image the 
HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas.   The Z-range is 100 






Figure 4.5.  12 μm x 12 μm scanning force micrograph height image of a patterned 
monolayer exposed to 100 μM beta amyloid in 10 mM KOH solution at pH 11 for 12 hours.  
Z-range is  50 nm. 
 
The patterned monolayers were analyzed with ex situ SFM at 12- and 48-hour intervals.  
After a 12-hour incubation period (Figure 4.4), the Aβ protein had begun to adsorb onto the 
alkanethiol-terminated monolayer.  Although the majority of the ethylene glycol-terminated 
monolayer remained protein free, several large Aβ protein aggregates (~500 nm) were present on 
the ethylene glycol-terminated monolayer.  When examining a close up height image, the edges 
of the pattern were sharply defined, as shown in Figure 4.5, indicating that the Aβ protein was 
mainly confined to the methyl-terminated monolayer.  At this point in time, the adsorptive 
properties for the two monolayers were what would be expected.   
 After the Aβ protein was exposed to the patterned monolayer for 48 hours, the protein 
had completely covered the methyl-terminated monolayer (Figure 4.6).  There were some large 
structures present on the surface that are attributed to defects in the gold.  The interface between 
the two monolayers was still clearly defined, but there was visible protein deposition on the 
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ethylene glycol-terminated monolayer.  Once again, when comparing the height SFM and 
friction LFM for the 48-hour incubation period, the ethylene glycol-terminated areas were lighter 
.  Under these experimental conditions, it appeared that while the Aβ protein adsorbed mainly on 
the HS(CH2)17CH3, it also migrated to the HS(CH2)11(OCH2CH2)3OH monolayer as was seen on 
the small scale pattern.  These results indicated that the spacing of the monolayers was not the 
culprit of the protein deposition onto the ethylene glycol-terminated monolayer on the smaller 




Figure 4.6.  20 μm x 20 μm scanning force micrographs of a patterned monolayer exposed 
to 100 μM beta amyloid in 10 mM KOH solution at pH 11 for 48 hours. The height image is 
on the left and the friction image is on the right.  In the friction image the 
HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas.  The Z-range is 50 nm 
for the height image and 1.0 V for the friction image. 
 
 
4.6  Deposition of Bovine Serum Albumin on a Patterned Monolayer 
 In order to determine the effect of the patterned monolayer on another protein, 
experiments were repeated using bovine serum albumin (BSA) as a control.  BSA is a 
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homogenous, sticky protein commonly used to test surfaces for fouling properties.19-21  The 
small- and large-scale patterned substrates were constructed as described previously and the BSA 
protein solution (100 μM in 15 mM PBS) was allowed to incubate on the patterned monolayers 
for 12- and 48-hour intervals.   
 The results of incubating the BSA protein on a small-scale patterned monolayer (5 μm 
and 2 μm stripes) for 48 hours are shown in Figure 4.7.  On this surface, the BSA protein 
remained confined to the fouling HS(CH2)17CH3 monolayer surface, unlike the Aβ protein 
experiments under the same conditions.  There was a minute amount (~ 0.6 aggregates per μm2) 




Figure 4.7.  10 μm x 10 μm scanning force micrographs of a patterned monolayer exposed 
to 100 μM bovine serum albumin in 15 mM PBS solution at pH 11 for 48 hours.  The height 
image is on the left and the friction image is on the right.  In the friction image the 
HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas.  The Z-range is 50 nm 
for the height image and 0.5 V for the friction image. 
 
The results of incubating the BSA protein on the large-scale substrate for 12 hours are 
shown in Figure 4.8.  The BSA protein appeared to only adsorb on the methyl-terminated areas 
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of the substrate.  After 48 hours (Figure 4.10), the deposition of the BSA protein was mostly 
limited to the methyl-terminated areas of the substrate although the deposition of BSA protein 
had branched onto the ethylene glycol-terminated areas.  The patterned edges were still easily 
discernable, which indicates that the BSA protein adsorbed mainly on the methyl-terminated 
surface.  In this case, the BSA protein behaved as expected in regards to fouling on the 
monolayers, even on the small scale pattern.  This indicates that mixing of the monolayers did 
not occur because the BSA protein would have adsorbed on the mixed monolayers.22, 23  
Therefore, it was assumed that mixing of the monolayers also did not occur on the patterned 
monolayer substrate used in the Aβ protein and that the Aβ protein actually attached on the 
surfaces with small-scale pattern. 
 
 
Figure 4.8.  81 μm x 81 μm scanning force micrographs of a patterned monolayer exposed 
to 100 μM bovine serum albumin in 15 mM PBS solution at pH 11 for 12 hours.  The height 
image is on the left and the friction image is on the right.  In the friction image the 
HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas.  The Z-range is 50 nm 






Figure 4.9.  33 μm x 33 μm scanning force micrographs of a patterned monolayer exposed 
to 100 μM bovine serum albumin in 15 mM PBS solution at pH 11 for 48 hours.  The height 
image is on the left and the friction images are on the right.  In the friction image the 
HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas.  The Z-range is 50 nm 
for the height image and 1.0 V for the friction image. 
   
4.7 Incubation of Beta Amyloid Supernatant from the HS-(CH2)17-CH3 Monolayer on  
the HS(CH2)11(OCH2CH2)3OH monolayer 
 
Because the deposition of Aβ protein on the patterned monolayers was probably not due 
to mixing of the monolayers, it was thought that the HS(CH2)17CH3 monolayer induced a change 
in protein conformation that allowed Aβ protein to adsorb to the HS(CH2)11(OCH2CH2)3OH 
monolayers.  In order to test this hypothesis, Aβ protein in 10 mM KOH at pH 11.5 was first 
incubated on the HS(CH2)17CH3 monolayer for 12 hours.  The Aβ protein supernatant was 
removed from the HS(CH2)17CH3 monolayer on Au and applied to the 
HS(CH2)11(OCH2CH2)3OH/Au substrate.  The Aβ protein solution was then incubated on the 
HS(CH2)11(OCH2CH2)3OH monolayer for 12 hours, then the monolayer was rinsed and analyzed 
with RAIRS.  Surprisingly, after incubation on the HS(CH2)17CH3 monolayer, the Aβ protein 
adsorbed to the surface of the  HS(CH2)11(OCH2CH2)3-OH monolayer (Figure 4.10).  After 
curve-fitting deconvolution was performed on the spectrum, it was confirmed that Aβ protein 
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was present only in a β-sheet conformation.  The resolved peaks were located at 1612, 1629, 
1639, 1673, and 1695 cm-1.  The peak at 1612 cm-1 is attributed to side chain interactions, while 
the remaining peaks are indicative of β-sheet structures.  Therefore, the HS(CH2)17CH3 
monolayer had the ability to induce a conformation that was able to adsorb to the previously non-
fouling HS(CH2)11(OCH2CH2)3OH monolayer.  Taken in relation to the patterned monolayer 
experiments, it can be concluded that the small areas of fouling HS(CH2)17CH3 monolayer had 
the ability to produce a class of Aβ protein that was folded in a way that allowed it to attach to 
the HS(CH2)11(OCH2CH2)3OH monolayer.   
























Figure 4.10.  Curve-fitting deconvolution of RAIR spectrum of supernatant of 100 μM Aβ 
in 10 mM KOH (pH 11.5) that was first incubated on HS-(CH2)17-CH3/Au for 12 h then 
removed and incubated on the HS(CH2)11(OCH2CH2)3OH monolayer for 12 hours.  
Original spectra (solid), fitted curve (dash-dot), and individual Gaussian components (dot) 
with a reduced χ2 value of 3.09. 
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Although ethylene glycol end groups are usually seen to be non-fouling, there are a few 
examples in literature that show protein to be attracted to ethylene glycol functionalities.  
Leckband et al. discovered that if streptavidin was forced into contact with a poly(ethylene 
glycol) chain, there existed reasonably strong attractive forces between the protein and the 
poly(ethylene glycol) moiety.24  It has also been shown that mucin, glycoproteins that line the 
gastrointestinal tract, adhere weakly to poly(ethylene glycol).25  Therefore, it is not unreasonable 
that the Aβ protein would adsorb to the HS(CH2)11(OCH2CH2)3OH monolayer.   
4.8 Effects of a Patterned Monolayer on the Aggregation of Beta Amyloid Protein in 
Solution 
 
Previous studies (Chapter 3) indicated that the Aβ protein can adsorb on a fouling 
monolayer, form larger aggregates and then desorb from the surface into solution where it acts as 
a nucleus for further aggregation in solution.  In the earlier studies analyzing the seeding effect 
of the monolayers, the alkanethiol monolayer induced the aggregation of the protein in solution, 
while the ethylene glycol-terminated monolayer did not affect the aggregation of the protein in 
solution.  Therefore, the effect of the combination of the surface fouling and non-fouling 
moieties on the aggregation of the protein in solution was also analyzed.  A comparison between 
the Aβ supernatant from the HS(CH2)17CH3 and the ethylene glycol-terminated monolayers and 
the patterned monolayers was conducted using scanning force microscopy.  The Aβ protein 
solution was taken off the monolayer surfaces, applied to mica, allowed to adsorb for five 
minutes, then rinsed and analyzed with SFM.  A high pH solution was used to impede the 
aggregates from forming in the solution.    
The results of the Aβ peptide solution taken from the ethylene glycol-terminated 
monolayer are displayed in Chapter 3, Figure 3.6.  Following incubation on the monolayer 
surface for 7 days, the solution had very few aggregates (approximately five aggregates per 100 
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μm2), with lengths ranging from 25 to 30 nm and heights of approximately 10 nm.  After a 7-day 
incubation of the Aβ solution with the HS(CH2)17CH3 monolayer, the Aβ protein had formed 
many more aggregates (approximately 55 aggregates per 100 μm2) in solution than did the 
sample from the HS(CH2)11(OCH2CH2)3OH monolayer.  The aggregates were approximately 
100 to 120 nm long and had heights of approximately 50 nm (Figure 4.11A).   
The solution from the patterned monolayers was analyzed in order to probe the effects of 
the patterned monolayer on the production of the Aβ aggregates in solution.  After 7 days of 
incubation, the Aβ protein had formed larger aggregates approximately 35 nm in height and 75 to 
90 nm in length (Figure 4.11B) with a population of approximately 50 aggregates per 100 μm2.   
 




Figure 4.11.  10 μm x 10 μm scanning force micrographs of 100 μM Aβ10-35 peptide in 10 
mM KOH solution at pH 11.5.  A. Supernatant from the HS-(CH2)17-CH3 /Au monolayer 
exposed to 100 μM Aβ10-35  peptide in 10 mM KOH for 7 days.  B. Supernatant from the 
HS-(CH2)17-CH3 and  HS(CH2)11(OCH2CH2)3OH patterned monolayer exposed to 100 μM 
Aβ10-35  peptide in 10 mM KOH for 7 days.  For the supernatant experiments, 50 μL of 
supernatant was spotted on mica, allowed to sit for 5 minutes, and then the resulting 
surface was rinsed with 18 MS-cm water and dried. Z-range=50 nm. 
 
After comparing the analysis of the Aβ solutions from all three surfaces, it was clear that 
the Aβ solution from the patterned monolayers favored the aggregation activities of the solution 
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from the HS(CH2)17CH3 monolayer rather than the solution from the HS(CH2)11(OCH2CH2)3OH 
monolayer.  The Aβ solution from the HS(CH2)17CH3 monolayer experiment had a much greater 
extent of peptide aggregation than the HS(CH2)11(OCH2CH2)3OH monolayer, as judged by 
aggregation length and number.  In comparison, the Aβ protein solution taken from the patterned 
monolayer made up of both the HS(CH2)17CH3 and the HS(CH2)11(OCH2CH2)3OH monolayers 
exhibited protein aggregation that was comparable to the HS(CH2)17CH3 monolayer.  It can be 
concluded that even small amounts of the HS(CH2)17CH3 in the patterned monolayers do induce 
aggregation of the Aβ peptide in solution to the same extent that the monolayer surface made 
entirely of HS(CH2)17CH3 did. 
4.9 Conclusions 
When the Aβ protein was incubated on a small-scale pattern of the fouling and non-
fouling monolayers, it appeared that the Aβ protein adsorbed onto the ethylene glycol even 
though the ethylene glycol-terminated monolayers alone were previously seen to be non-fouling.  
Since the Aβ protein was present on the ethylene glycol-terminated portion of the monolayer, it 
appeared that the adsorptive characteristics of the methyl-terminated monolayer were greater 
than the protein-resistant properties of the ethylene glycol-terminated monolayer.  It seemed that 
the Aβ protein nucleated on the fouling monolayer, then desorbed from the fouling monolayer 
and readsorbed on the non-fouling monolayer surface.  On the large-scale patterned monolayer, 
it appeared that the Aβ protein did adsorb on the HS(CH2)17CH3, and migrated to the 
HS(CH2)11(OCH2CH2)3OH monolayer although not to the extent that was seen on the small scale 
pattern.  A possible reason that there was less protein present on the larger-scale pattern than the 
small-scale pattern could be that after the Aβ protein desorbed from the surface, the protein did 
not travel far before it readsorbed on the surface; therefore, the length of diffusion of the protein 
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was not great.  On the large-scale pattern monolayer configuration, the domain constraints of the 
surface have more of an effect on the deposition of the protein on surfaces.   When the Aβ 
protein was first incubated on the HS(CH2)17CH3 monolayer alone, removed and then incubated 
on the HS(CH2)11(OCH2CH2)3OH  monolayer, the protein adsorbed on the HS(CH2)11-
(OCH2CH2)3OH  monolayer.  This was surprising because when the freshly-made Aβ protein 
was incubated on the HS(CH2)11(OCH2CH2)3OH  monolayer, the HS(CH2)11(OCH2CH2)3OH  
monolayer was non-fouling for up to 40 days.  This was important because it appears that the 
HS(CH2)17CH3 monolayer can induce a change in conformation that allows the protein to attach 
to what are normally non-fouling surfaces.  When analyzing the BSA protein on the patterned 
surface, the protein behaved as expected in regards to fouling on the monolayers, even on the 
small-scale pattern.   
The effect of the patterned monolayer on the aggregation of the Aβ protein in solution 
was investigated.  It was clear that the Aβ solution from the patterned monolayers favored the 
aggregation behavior of the Aβ solution from the HS(CH2)17CH3 monolayers rather than the Aβ 
solution from the HS(CH2)11(OCH2CH2)3OH monolayer.  The Aβ solution from the 
HS(CH2)17CH3 monolayer experiment had a much greater extent of peptide aggregation than the 
HS(CH2)11(OCH2CH2)3OH monolayer, as judged by aggregation length and number.  In 
comparison, the Aβ protein solution taken from the patterned monolayer made up of both the 
HS(CH2)17CH3 and the HS(CH2)11(OCH2CH2)3OH monolayers exhibited protein aggregation 
that was comparable to the HS-(CH2)17-CH3 monolayer.  It can be concluded that even small 
areas of fouling monolayer embedded in a non-fouling monolayer can induce aggregation of the 
Aβ peptide in solution.  This is important because it establishes that in the brains of humans it is 
possible that a particular type of isolated chemical functionality on the cell membrane can act as 
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a nucleation site for inducing aggregation of Aβ protein on a surface that would not usually 
affect the Aβ protein.   
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Interaction of Beta Amyloid Protein with Lipid Bilayers 
 
5.1  Introduction 
There is evidence that Aβ fibril assembly is effected by interactions with biological 
surfaces by inducing β sheet aggregation.1-3 In addition, it has been shown that the presence of 
negatively charged lipid vesicles in Aβ solutions shifts the random coil conformation of Aβ 
peptide to a β–sheet conformation under conditions of low ionic strength.1, 2   This is due to the 
electrostatic binding of Aβ peptide onto the lipid membrane surface and subsequent aggregation 
of the peptide.3  Consequently, it is possible that some type of moiety on the cell surface triggers 
the folding of Aβ peptide and subsequent plaque formation.    
It has also been proposed that the toxicity of the Aβ protein is due to the interactions it 
has with the cell membranes.  The toxicity is possibly caused by the formation of ion channels 
when the Aβ protein inserts into the cell membrane, which would disrupt the homeostasis of the 
cell, leading to cell death.4-6  Since the Aβ peptide is cleaved from the Aβ precursor protein 
within the cell membrane, it is possible that the Aβ peptide inserts itself back into the cell 
membrane after cleavage.  The Aβ peptide would then be attached to the cell membrane, 
providing a nucleus for subsequent protein aggregation.   Therefore, it is critical to investigate 
the interaction of Aβ peptide and model membranes with each other.  Lipid bilayers were chosen 
to represent the cell membranes. 
The goal of the work described here is an understanding of the effects of lipid membranes 
on the aggregation of beta amyloid (Aβ) peptide and the effect of the Aβ peptide on the lipid 
bilayer.  Mica-supported lipid bilayers consisting of 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-
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Phosphocholine (POPC) and 1-Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino] 
dodecanoyl]-sn-Glycero-3-Phosphocholine (NBD-PC) were used as a model cell membrane 
system.  Lipid bilayers are physiologically significant because phospholipids are the principle 
components of cellular membranes and POPC is one of the main elements of mammalian cell 
membranes.7, 8  These model surfaces were used to determine the effect of the lipid bilayers on 
the binding, deposition, and aggregation of the Aβ peptide.   Fluorescence photobleaching 
recovery (FPR), fluorescence microscopy, and in situ scanning force microscopy (SFM) were 
chosen to evaluate the effect of Aβ protein on the lipid bilayers.   
5.2 Composition of Fluorescently Labeled Lipid Bilayers 
Small, unilamellar lipid vesicles were constructed using the Morrissey protocol and were 
subsequently adsorbed onto mica substrates using vesicle fusion to form the lipid bilayers.9, 10  
The lipid bilayers were first analyzed using fluorescence microscopy (Figure 5.1).  The image 
shows a surface that has some wavelike patterns with higher fluorescence intensity that is 
attributed to the fact that the lipid bilayer was moving even when the image was being obtained.  
The camera captured the movement and produced these patterns.  This image indicated that a 
lipid bilayer was formed using this method.   
 
Figure 5.1.  Fluorescence microscopy image of 5% NBD-PC / 95% POPC lipid bilayer on 
















Figure 5.2.  Fluorescence photobleaching recovery of 100% NBD-PC lipid bilayer on mica 
that was not rinsed after lipid bilayer formation.  The diffusion coefficient was found to be 
6.63 x 10-8 ± 3.08 x 10-9 cm2s-1.   
 
Initial analysis was done using lipid bilayers made with different proportions of POPC 
and NBD-PC to determine the correct ratios of the two lipids and the correct method for making 
the lipid bilayers.  Preliminary analysis was performed using 100% NBD-PC vesicles in 
phosphate buffer solution to determine the diffusion coefficient of the lipid bilayers.  In the first 
experiment, the lipid bilayers were fused onto the mica surface and analyzed without rinsing the 
surface after the bilayer had formed (Figure 5.2).  The diffusion coefficient was calculated to be 
6.63 x 10-8 ± 3.08 x 10-9 cm2s-1.  Next, the bilayers were formed and they were then rinsed with 
phosphate buffer solution after the bilayer had formed in order to remove any unadsorbed lipid 
vesicles (Figure 5.3).  After the lipid bilayers were analyzed, the diffusion coefficient was 
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calculated to be 6.65 x 10-8 ± 7.17 x 10-9 cm2s-1, which was comparable to the unrinsed lipid 
bilayers.   
Since the NBD-PC lipids do not exist in nature and a high concentration of a fluorescent 
label can cause quenching that leads to errors in the diffusion coefficient, a mixture of POPC and 
NBD-PC was used.  Initial concentrations were 20% NBD-PC and 80% POPC.  This mixture 
produced a totally quenched sample that had no fluorescence signal.  Next, a 10% NBD-PC and 
90% POPC mixture was used that also produced a quenched sample.   
 









Figure 5.3.  Fluorescence photobleaching recovery of 100% NBD-PC lipid bilayer on mica 
that was rinsed after bilayer formation.  The diffusion coefficient was found to be 6.65 x   
10-8 ± 7.17 x 10-9 cm2s-1. 
 
Finally, a 5% NBD-PC and 95% POPC sample was made that produced a viable 
fluorescence signal.  After the lipid bilayer was formed on mica, the sample was rinsed with 
phosphate buffer solution to eliminate any nonfused lipid vesicles.  Analysis was done using 
FPR to obtain the diffusion coefficient (Figure 5.4).  The diffusion coefficient from these 
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experiments was 5.99 x 10-8 ± 5.51 x 10-9 cm2s-1, which was comparable to the 100% NBD-PC 
lipid bilayer sample.   
 


















Figure 5.4.  Fluorescence photobleaching recovery of 5% NBD-PC / 95% POPC lipid 
bilayer on mica that was rinsed after bilayer formation.  The diffusion coefficient was 5.99 
mation of Fluorescently Labeled Lipid Bilayers with In Situ 
Scanning Force Microscopy 
The for  lipid vesicles was analyzed using in situ SFM.  Figure 
x 10-8 ± 5.51 x 10-9 cm2s-1.   
 
5.3 Analysis of the For
 
mation of the lipid bilayers from
5.5 depicts the topography of the 5% NBD-PC / 95% POPC lipid bilayer surfaces during their 
formation on a mica support.  Initially, the surface had a lamellar structure with completely 
planar layers.  The thickness was considerably higher (~ 40 nm) than that of a typical POPC lipid 
bilayer (Figure 5.2A).11  After approximately 12 minutes, (Figure 5.2B) the lipid bilayer had 
formed with a few defects.  Before the lipid bilayer was rinsed, there were a few nonfused 
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vesicles present on the surface (Figure 5.2C).  After the lipid bilayer surface was rinsed with 











Figure 5.5.  In situ scanning force microscopy images of lipid vesicles (5% NBD-PC / 95% 
POPC in phosphate buffer solution) forming a lipid bilayer on a mica surface.  A.  Initial 
 
image of lipid vesicles on mica.  Z-range = 50 nm.  B.  Lipid bilayer begins to form after 4 
minutes deposition time.  Z-range = 100 nm  C.  Nonfused lipid vesicles on the lipid bilayer 
surface before rinsing.  Z-range = 50 nm.  D.  Lipid bilayer after rinsing with phosphate 
buffer solution. Z-range = 20 nm.   
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Following the formation of the supported lipid bilayer, analysis was done to determine 
the thickness of the bilayer.  A high tip force (deflection setpoint = 10 V) was used to scrape 
away the bilayer while scanning in a 3 μm x 3 μm area.  After four scanning cycles, the tip force 
was reduced to a normal force (deflection setpoint = 2 V) and the scanning area was enlarged to 
10 μm x 10 μm, which allowed for imaging of the bare area in the lipid bilayer so that a depth 
profile analysis could be performed (Figure 5.6A).  Section analysis was performed to create a 
height profile of the lipid bilayer (Figure 5.6B).  The thickness of the bilayer was approximately 






Figure 5.6.  A.  In situ scanning force microscopy image of 5% NBD-PC / 95% POPC lipid 
bilayer on mica.  A high tip scanning force was used to scrape away the bilayer and then 
the scanning area was enlarged using a normal tip scanning force for a depth profile 
analysis.  B.  Height profile of the lipid bilayer; the thickness of the bilayer is 




5.4 teraction of Beta Amyloid Peptide with Lipid Bilayers 
o determine if the Aβ peptide interacted with the lipid bilayers, thioflavin-T-labeled 100 




μM 10-35 peptide fibrils were incubated for one hour on a 100% P
a.  Thioflavin-T is a fluorescent dye that binds to the hydrophobic core of the Aβ protein 
and allows the Aβ peptide to be imaged with a fluorescence microscope.  The preformed Aβ 
fibrils were approximately 25 μm in length.  After the exposure time was complete, the lipid 
bilayer was rinsed with phosphate buffer solution.  Initial analysis was done using fluorescence 
microscopy (Figure 5.7).  The Aβ peptide fibrils appeared to have a strong interaction with the 
lipid bilayers since the fibrils were still present on the surface even after rinsing.   
 
Figure 5.7.  Fluorescence microscopy image of 100% POPC lipid bilayer on mica exposed 
to preformed, thioflavin-T labeled 100 μM Aβ10-35 peptide fibrils for one hour.   
 
the lipid bilayers.  Preformed Aβ1-40 protein fibrils were incubated on the 5% NBD-PC / 95% 
POPC 
FPR analysis was done to determine the effect of the Aβ protein fibrils on the fluidity of 
lipid bilayers over a period of five hours (Figure 5.8).  During this time, the diffusion 
coefficient of the lipid bilayers decreased from 5.99 x 10-8 cm2 s-1 to 8.3 x 10-9 cm2 s-1, indicating 
that the Aβ protein interacted with the lipid bilayers.  It is thought that the Aβ protein fibrils 
interacted with the lipid bilayers because the hydrophobic areas of the Aβ protein were attracted 
to the interior hydrophobic tail regions of the lipid bilayer.   
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The interaction of the Aβ peptide with the lipid bilayers was also monitored with in situ 
scanning force microscopy.  The 5% NBD-PC / 95% POPC lipid bilayer was formed as 
described previously and imaged to ensure that a defect-free surface had formed.  The freshly-
made Aβ10-35 peptide was then added to the lipid bilayer.  Perturbations began to form in the lipid 
bilayer after approximately ten minutes.  After approximately one hour, the Aβ peptide began to 
insert into the lipid bilayer causing further defects in the surface (Figure 5.9).  This is illustrated 
by the presence of a Aβ peptide aggregate in the middle of a hole in the lipid bilayer.  The Aβ 
peptide appears to have caused pore-like defects in the lipid bilayer surface.  It should be noted 
that when the lipid bilayer was imaged with a Aβ peptide-free phosphate buffer solution (control) 
no defects formed in the surface for comparable incubation times.    
4.0



























Figure 5.8.  Diffusion coefficient of preformed beta amyloid 1-40 fibrils incubated on 5% 
















y image of 5% NBD-PC / 95% POPC lipid 
phate buffer solution for one hour; B. 100 μM 
for one hour; C. Zoom image of 100 μM Aβ10-
Figure 5.9.  In situ scanning force microscop
bilayer on mica exposed to:  A. 15 mM phos
Aβ10-35 peptide (in phosphate buffer solution) 
35 peptide (in phosphate buffer solution) for one hour; D.  Height profile of the lipid bilayer 
and beta amyloid protein aggregate.  Z-range = 50 nm. 
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5.5 Interaction of Nystatin with Lipid Bilayer
For comparison purposes, the interaction of nystatin, an antimicrobial agent, with the 
lipid bilayer system was examined.  Nystatin, which is used as an antifungal medicine, is known 
to insert into lipid bilayers.12-14  The nystatin (10 μM in 15 mM phosphate buffer solution) was 
applied to a 5% NBD-PC / 95% POPC lipid bilayer and allowed to incubate for 24 hours.  The 
surface was rinsed with phosphate buffer and imaged using in situ contact mode SFM.  It 
appeared that the nystatin attached to the lipid surface and disrupted the lipid membrane.  The 
nystatin aggregates were 500 nm in length and 25 nm in height.  When compared to the results of 
the Aβ peptide, it appeared that the Aβ peptide disrupted the lipid bilayer more than the nystatin 






Figure 5.10.  In situ scanning force microscopy image of 5% NBD-PC / 95% POPC lipid 
B.  Zoom view of Figure 5.10A.  Z-range = 50 nm. 
 
 





5.6 Effect of Lipid Bilayers on the Aggregation of Beta Amyloid Peptide 
The effect of the lipid bilayers on the aggregation of the monomeric Aβ10-35 peptide was 
analyzed.  The Aβ peptide was dissolved in KOH solution with a high pH (pH ~ 11.5) to prevent 
aggregation.  The Aβ peptide was incubated on the 5% NBD-PC / 95% POPC lipid bilayers.  
The Aβ peptide solution was removed from the lipid bilayer surface and applied to mica, which 
allows for the solution phase deposition of protein.  The samples were then analyzed using SFM.  





Figure 5.11.  In situ scanning force microscopy images of supernatant from lipid bilayer 
from the 5% NBD-PC / 95% POPC lipid bilayer on mica exposed to 100 μM Aβ10-35 peptide 
in 10 mM KOH solution at pH 11.5 for 48 hours; Z-range = 100 nm (A).  Supernatant from 
lipid bilayer from the 5% NBD-PC / 95% POPC lipid bilayer on mica exposed to 10 mM 
KOH solution at pH 11.5 for 48 hours; Z-range = 10 nm (B).  50 μL of supernatant was 
spotted on mica, allowed to sit for 5 minutes, and then the resulting surface was rinsed with 
18 MΩ-cm water and dried.  
 
in solution.  A control consisting of a  Aβ peptide-free KOH solution incubated on a lipid bilayer 
for the same amount of time and the applied to mica was used for comparison (Figure 5.10B).  
This sample had none of the large structures characteristic of the Aβ peptide solution.  Therefore, 
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it can be concluded that the large, amorphous structures that resulted when the Aβ peptide 
solution was incubated on the lipid bilayer are truly Aβ peptide and not portions of the lipid 
bilayer that has disassembled because of the KOH (control) solution.   
5.7 Conclusions 
The interaction of the Aβ peptide the lipid bilayers was analyzed using FPR and in situ 
SFM.  FPR was used to monitor the fluidity of the bilayers.  The baseline fluidity of the lipid 
bilayers was established, and then the Aβ protein was incubated on the bilayers.  It was 
demonstrated that the fluidity of the lipid bilayers was reduced when incubated with Aβ peptide, 
ting that there was an interaction with the lipid bilayers and the protein.  The interaction of 
rotein, because if pores formed, they would act as ion channels.  These ion channels would 
n act as a seeding nucleus 
urt n of the protein to form.   
indica
the protein with the bilayer was further analyzed with in situ SFM.  The in situ SFM revealed 
that the Aβ peptide actually physically disrupted the lipid bilayers causing pores to form in the 
lipid bilayers.  It is thought that the hydrophobic groups of the Aβ peptide interact with the 
hydrophobic inner areas of the lipid bilayer.  This is a useful model of the cytotoxicity of the 
p
disrupt the cellular homeostasis, which would lead to cell death.4   
The Aβ protein solution that was incubated on the lipid bilayers was also examined.   The 
solution showed evidence of extensive Aβ peptide aggregation, indicating that the lipid bilayers 
induced aggregation of the peptide in solution.  This information is important because it provides 
evidence about the formation of amyloid plaques in the brains of humans.  It is possible that the 
Aβ protein inserts into the lipid bilayer and is immobilized where it ca
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Outcomes, Conclusions and Future Direction 
 
6.1 Summary of Outcomes and Conclusions 
6.1.1 Surfaces Can Induce Aggregation of Beta Amyloid Peptide in Solution 
Reflection-absorption infrared spectroscopy (RAIRS) analysis revealed that adsorption of 
Aβ occurred onto both hydrophilic and hydrophobic surfaces under conditions that normally do 
not lead to aggregation in solution.  In addition, the RAIRS studies demonstrated that the 
conformation of the adsorbed Aβ10-35 does not change over a period of 40 days of exposure, and 
the amount of Aβ deposited increases with exposure time.  Scanning force microscopy (SFM) 
confirmed that the amount of aggregated deposits increased with exposure time.  Studies of the 
solutions exposed to monolayers revealed that the monolayers have a seeding effect on Aβ 
peptide in solution, leading to the conclusion that monolayers actually induce aggregation of Aβ 
peptide in solution.   
6.1.2 Adsorptive Behavior and Aggregation Properties of Beta Amyloid Peptide on 
Patterned Surfaces 
 
Patterned surfaces made up of fouling (HS(CH2)17CH3) and non-fouling 
(HS(CH2)11(OCH2CH2)3OH) monolayers were constructed to determine how these different 
areas would affect the aggregation and adsorption of the Aβ protein.  When the Aβ protein was 
incubated on a small-scale pattern (~ 1 μm repeat pattern) of the fouling and non-fouling 
monolayers, it appeared that the Aβ protein adsorbed onto the ethylene glycol even though the 
ethylene glycol-terminated monolayers alone were previously seen to be non-fouling.  Because 
the Aβ protein was present on the ethylene glycol-terminated portion of the monolayer, it seemed 
that the adsorptive characteristics of the methyl-terminated monolayer were greater than the 
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protein-resistant properties of the ethylene glycol-terminated monolayer.  It appeared that the Aβ 
protein nucleated on the fouling monolayer, then desorbed from the fouling monolayer and 
readsorbed on the non-fouling monolayer surface.  On the large-scale patterned monolayer (~ 10-
30 μm repeat pattern), it appeared that the Aβ protein adsorbed mainly on the HS(CH2)17CH3, but 
also adsorbed on the HS(CH2)11(OCH2CH2)3OH monolayer although not to the extent that was 
seen on the small scale pattern.  It was determined that the HS(CH2)17CH3 monolayer must alter 
the Aβ protein in such a way that allows it to adsorb to the HS(CH2)11(OCH2CH2)3OH 
monolayer.  In order to test this theory, the Aβ protein was first incubated on the HS(CH2)17CH3 
monolayer alone, removed and then incubated on the HS(CH2)11(OCH2CH2)3OH  monolayer 
alone.  Subsequently, the Aβ protein adsorbed on the HS(CH2)11-(OCH2CH2)3OH  monolayer.  
This was surprising because when freshly-made Aβ protein was incubated on the 
HS(CH2)11(OCH2CH2)3OH  monolayer, the HS(CH2)11(OCH2CH2)3OH  monolayer was non-
fouling for up to 40 days.  This was important because it appears that the HS(CH2)17CH3 
monolayer can induce a change in conformation that allows the protein to stick to what are 
normally non-fouling surfaces.   
The effect of the HS(CH2)17CH3 / HS(CH2)11-(OCH2CH2)3OH  patterned monolayer on 
Au on the aggregation of the Aβ protein in solution was investigated.  It was clear that the Aβ 
solution from the patterned monolayers favored the aggregation behavior of the solution from the 
HS(CH2)17CH3 monolayers rather than the solution from the HS(CH2)11(OCH2CH2)3OH 
monolayer.  The Aβ solution from the HS(CH2)17CH3 monolayer experiment had a much greater 
extent of peptide aggregation than the HS(CH2)11(OCH2CH2)3OH monolayer, as judged by 
aggregation length and number gain from the SFM experiments.  In comparison, the Aβ protein 
solution taken from the patterned monolayer made up of both the HS(CH2)17CH3 and the 
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HS(CH2)11(OCH2CH2)3OH monolayers exhibited protein aggregation that was comparable to the 
HS-(CH2)17-CH3 monolayer.  It can be concluded that even small areas of fouling monolayer 
embedded in a non-fouling monolayer can induce aggregation of the Aβ peptide in solution.  
This is important when a parallel is made between this study and physiological circumstances.  If 
there are small areas of chemically different of damaged cell membranes in the human brain, 
normally insoluble Aβ peptide may be conformationally changed to a type of protein that can 
attach to normal areas of the brain and form plaques.   
6.1.3 Interaction of Beta Amyloid Peptide with Lipid Bilayers 
The interaction of the Aβ peptide with lipid bilayers was analyzed using fluorescence 
photobleaching recovery (FPR) and in situ SFM.  FPR was used to monitor the fluidity of the 
bilayers by photobleaching areas of the fluorescent bilayer sample and recording the lateral 
motion as the bleached areas mix with the unbleached areas.  The baseline fluidity of the lipid 
bilayers was established, and then the Aβ protein was incubated on the bilayers.  It was 
demonstrated that the diffusion coefficient of the lipid bilayers was reduced when incubated with 
Aβ peptide, which indicated that there was an interaction between the lipid bilayers and the 
protein.  The interaction of the protein with the bilayers was further analyzed with in situ SFM 
and revealed that the Aβ peptide actually physically disrupted the lipid bilayers and caused pores 
to form in the lipid bilayers.  It is probable that the hydrophobic groups of the Aβ peptide interact 
with the hydrophobic inner areas of the lipid bilayer, which causes the Aβ peptide to insert itself 
into the lipid bilayer.  This is a useful model of the cytotoxicity of the protein, because if pores 
formed in a cell membrane, they would act as ion channels.  These ion channels would disrupt 
the cellular homeostasis, which could lead to cell death.1   
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The Aβ protein solution that was incubated on the lipid bilayers was also examined.   The 
solution showed evidence of extensive Aβ peptide aggregation, indicating that the lipid bilayers 
induced aggregation of the peptide in solution.  This information is important because it provides 
evidence about the formation of amyloid plaques in the brains of humans.  It is possible that the 
Aβ protein inserts into the lipid bilayer and is immobilized where it can act as a seeding nucleus 
for further aggregation of the protein to form.   
6.2 Future Directions 
6.2.1 Interaction of Lipids with Known Inserting Proteins 
It was seen that the Aβ protein inserted into lipid bilayers under certain experimental 
conditions.2, 3  For comparison purposes, the interaction of other proteins with the lipid bilayer 
system describe here should be examined.  Several antimicrobial proteins, such as protegrin-1, 
are known to insert into lipid bilayers.4-12  It has been well documented that this protein inserts 
into lipid bilayers and membranes, and it would be helpful to examine protegrin-1 under the 
same conditions as the Aβ protein was studied for comparison purposed.  It would also be useful 
to inspect the interaction of the amylin protein with the lipid bilayers.  Amylin is a protein 
associated with Type 2 Diabetes and is similar in structure to the Aβ protein.13, 14  It has been 
shown that the amylin protein inserts into lipid bilayers and vesicles, therefore it could be 
compared with the insertion of the Aβ protein into lipid bilayers.   
It would also be helpful to study the interaction of Aβ protein with various other types of 
lipids and different compositions of lipid membranes.  Membranes with composed of mixtures of 
anionic lipids, such as dipalmitoylphosphatidylglycerol, cationic lipids, such as dipalmitoyl-
trimethylammonium propane, and zwitterionic lipids, such as dipalmitoylphophatidylcholine, 
should be analyzed.15, 16    
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6.2.2 Interaction of Aggregation-Inhibitor Peptides with Lipid Bilayers 
It has been confirmed that the inhibitor peptides synthesized by the Hammer Group 
(AMY-X) can interact with the Aβ protein assembly.17-19  It is proposed that these inhibitors will 
have an effect on the interaction of the Aβ protein with the lipid bilayers.  It was seen previously 
that the interaction of the Aβ protein with lipid bilayers affected the lipid bilayer fluidity and 
physically disrupted the bilayers.  It is possible that the AMY-X inhibitors will be able to curb 
the interaction of Aβ protein with lipid membranes.  This hypothesis should be studied using 
FPR and in situ SFM. The fluidity of lipid membranes exposed to Aβ protein in the presence of 
AMY-X will be examined using by FPR and the assembly will be imaged using in situ SFM.   
6.2.3 Detection of Biomarkers for Alzheimer’s Disease 
Microcontact printing has become a useful tool in the manufacture of microanalytical 
devices, such as chemical and biological sensing devices.  The evolution of cell and protein 
arrays depends largely on developing techniques that control topographical features and spatial 
presentation of surface molecules, such as microcontact printing.  These arrays can be used for 
drug discovery, diagnostic assays and biosensors.  With the discovery of a biological marker for 
the detection of Alzheimer’s disease,20 microanalytical devices can now be developed to detect 
Alzheimer’s disease.  Microcontact printing is a viable option for the construction of such 
detection devices.   
Patterning and immobilization of biologically active moieties with micrometer and 
nanometer scale control has proven integral to a range of applications in basic research, 
diagnostics and drug discovery.  Future goals could be to capture Aβ protein in a specific 
orientation using microcontact printing and then use for other applications such as high 
throughput detection systems for drug development and for detection of Alzheimer’s disease.  It 
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is possible to orient the Aβ protein specifically so that a β-sheet conformation is produced while 
maintaining the biomolecular behavior of the patterned Aβ protein.  Detection systems that 
employ the Aβ-specific antibody could also be developed using patterned monolayers.   
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Deconvolution of Infrared Spectra 
When infrared spectroscopy is performed on proteins that are oriented in different 
secondary structures, the spectroscopic bands sometimes overlap, as is seen in the amide bands 
of the Aβ peptide.  When this happens, curve-fitting band deconvolution must be performed to 
resolve the overlapped peaks that occur when two or more protein conformations are present. 
Infrared spectroscopy works by inducing a molecular vibration in a molecule.  Energy is 
absorbed when the frequency of the radiation matches the frequency of the vibration of the 
molecule and causes a transition where the molecule goes from the ground vibronic state to an 
excited vibronic state; this results in the vibrational spectrum.  After the molecules are excited, 
they quickly return to the ground state.  This relaxation is called the amplitude lifetime, τa.  When 
the transition initially occurs, all of the excited molecules vibrate simultaneously, but the 
molecules begin to vibrate out of sequence with each other as difference in motion and 
vibrational frequencies take over.  This randomization is called the coherence lifetime, τc.  As the 
vibrations become chaotic, the components begins to interfere with each other and dephase, 
giving rise to the effective lifetime, τ, which is a combination of the τa and τc components.1   
Several factors must be determined when performing curve fitting.  One of these is the 
type of peak function to use.  The type of function depends on the relationship between τa and τc.  
When τc >> τa, the excited molecule relaxes before incoherence becomes significant and the IR 
peak has a Gaussian shape.1  In this situation, a Gaussian function will resolve the overlapped 
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where x0 is the position (frequency) of the peak, H is the peak height (intensity), and w is the line 
width which is given as the full width at half height value.2 
When τc << τa, the incoherence happens quickly, and dephasing of the molecular 
vibrations is prominent.1  The shape of these overlapped peaks is sharp in the center with long 
wings sloping down from the center.  A Lorentzian function will help resolve overlapped peaks 










      Equation A.2 
The GRAMS32 program chooses the best fit based on the experimental relationship 
between τa and τc.  In the work described here, the Gaussian function was used to resolve the 
peaks since τc >> τa.   
Another parameter affecting the correctness of fit is the number of peaks present.  Fit is 





















χ     Equation A.3 
where the Actual and Calculated variables are the measured and calculated intensity data, 
respectively, and the RMS Noise value is the estimated root mean squared noise in the actual 
data.2  The value n-f is the number of degrees of freedom in the data set, where n is the number 
of data points in the fitted region and f is the total number of variables from all the peak and 
baseline functions.2  If too many peaks are chosen a better fit will be produced, but some of the 
resolved peaks may be invented by the program to produce the fit.  If too few peaks are chosen, a 
peak that is actually present will not be resolved, and this will result in a poor fit.  Therefore, a 
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Fourier self-deconvolution (FSD) must be performed before the curve fitting process to 
determine how many unresolved peaks are actually present.  A Fourier transform (FT) is first 














    Equation A.4 
where the coefficient 0.5 Ai0γi is directly proportional to the area of the peak, the cosine term 
depends on the center wavenumber of the peak, and the exponential decay term is the 
deconvolution filter.3  An inverse FT function is then applied to the data to fully resolve the 
spectrum.  The inverse FT function is achieved by multiplying F(x) by exp(2πγ’x) to give the 









   Equation A.5 
After the peaks are resolved, a goodness of fit parameter, χ2, is calculated.  Typically, a χ2 value 
less than 10 is deemed acceptable.2   
To determine if the program worked accurately under the parameters that were set, a test 
was done.  Three peaks were made up using the Excel program.  These peaks were added 
together to produce a mock overlapped peak, as is shown in Figure A.1.  The resulting peak was 
imported into GRAMS/32 where the FSD and curve fitting functions were performed using the 
Gaussian function to resolve the peaks.  The results are depicted in Figure A.2.  When the 
starting data and the processed data are plotted in the same graph, the curve fitted peak match up 
almost exactly (χ2 = 1.2) with the original peaks (Figure A.3).  This proves the accuracy of the 
GRAMS/32 program in resolving the overlapped peaks, provided the correct parameters are 
used.   
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Figure A.1.  Peak created in Excel and added together to produce an imaginary overlapped 
peak.   













  Curve Fit Peak 1
  Curve Fit Peak 2
  Curve Fit Peak 3
 
Figure A.2.  Peaks resulting from curve fitting and deconvolution of the imaginary 
overlapped peak. 
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 Imaginary Peak 2
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Figure A.3.  Peaks created in Excel and added together to produce an imaginary 
overlapped peak combined the peaks resulting from curve fitting and deconvolution of the 
imaginary overlapped peaks.   
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Figure A.4.  Deconvoluted RAIR spectra of HS-(CH2)17-CH3/Au exposed to aqueous 
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 15 h.  Original spectra (dash), fitted 
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 5.2. 
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Figure A.5.  Deconvoluted RAIR spectra of HS-(CH2)15-COOH/Au exposed to aqueous 
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 15 h.  Original spectra (dash), fitted 
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 
10.0.   
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Figure A.6.  Deconvoluted RAIR spectra of HS-(CH2)10-SO3H/Au exposed to aqueous 
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 15 h.  Original spectra (dash), fitted 
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 2.0.   
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Figure A.7.  Deconvoluted RAIR spectra of HS-(CH2)11-OH/Au exposed to aqueous 
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 15 h.  Original spectra (dash), fitted 
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 9.1.   
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Figure A.8.  Deconvoluted RAIR spectra of CF3-(CF2)7-(CH2)2-SH/Au exposed to aqueous 
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 15 h.  Original spectra (dash), fitted 
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 5.3.   
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Figure A.9.  Deconvoluted RAIR spectra of CF3-(CF2)7-(CH2)2-SH/Au exposed to aqueous 
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 7 days.  Original spectra (dash), fitted 
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 4.3. 
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Figure A.10.  Deconvoluted RAIR spectra of CF3-(CF2)7-(CH2)2-SH/Au exposed to aqueous 
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 20 days.  Original spectra (dash), 
fitted curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value 
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